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A.

Pharmacological Action and Oherdcal Structure in the 'Barbituric

Aeid Derlvlltive Sen_.
,(1)

PrepaNt111n,_tiJod&.

In 'beginning the dUCWJ8ton ot this topic it is perUDant to preaent
801le

or the fundamental pl"1no1ples 01 the methods used in the 81Jltbesia ot

the barb! turie acid series.
Barbituric aaid is qnthetiHd by' condensation 01 urea yith the

d1eth71esteJt ot .:tonio acid in the presence ot sodium ethox1de.
membered ring ot barbituric acid is known either

&8

a

~d1ne

!be six-

or .. a

l,l-d1u1ne 1'1111. (Fieser and Fieaer, 19$0).

/NH~H
:.....

CO

"NHr'"
Jj

"r.···.··,,··..

~

(4)

H

0

~-c..C H ")
+ CLHsdoc
............ ~ 'CH 6.' or IH~ ''''CO

~H"'aO~
so •

.............;

,1'4Q

2.

'"I.i

~" N-c/
H

0

(0

(6)

1.\5

111. derivatives ot})vbi tunc acid are valuable agents in medicine
and an COM!IIOnq known as ttbarbi tul"8tes ft •
F.. Fischer and von 'M'erJ"lng in

acid .. a ~t1c drug.

1903.

'!he pioneers in this field were

'!hey in troduced

(l"1eeer and F'1eser, 19$0).

1

5,S...dieth¥l barb! tune

2
"
1t1e synthesis of a "barbiturate" oan be Ulutrated by the following

example.

It a derivative

ot barbiturio acid

with two identical al.kyl rad10ala

on 0U'b0n tive is de8ired one proceeds in the tollov1ng ft7l
(,3)

/'N H(H'

CO
"

~ ...... +
:'....

C~'H~'O~C,CR... Na.v~
rv-H
/~-~,CR. . +~ 'C,.H... OH
;(tJco
<,5)

......... ".!
,.t

~

II ••••••••

N H~H
U'f"t

l&t)

'N-C
H
0

C2.Hs<l:OC/
.I., •• , ••••~

__

~;&.

.~

16 1

(II

It 'bfo ditferent earbon tive Bubstttutione are desired one has to
prepare the mon08ubatt t.uted Jl&1.oni c ester

usmc

't.!'le toUowingmethod (Burpr,

19S1):

N= CC H2.COCR' + O=CR~ -~) N=C~COOR+ H~O
CR"~
N~CCCOORI

CR"

+ Hl.

-~) N~C CHeDORI

+ RIOH

Hl.O) R'OOC.C.HCOOR'

<t

N=cc HCOO~:
HC~',.

HCR~

HCp.:~

1b1s p1"OO«lu.re 18 required becau8e the reaction tor direot 1ntroduc-

tdon ot one al.1q'1 radioal cannot be wen controlled, giving '. JIIlxture of the,
mono- and dieubaU .. ted malon1e acid eaten.

Their steM tl"act.ioning 18

rather d1tt1eult eapec1a117 in c.... where small radlO&la are introduced.

second alkyl radical is added by the conventional _thode.

'lbe

'lbe diaubstituted

malonic acid eater obtained is condensed with urea u described in preC«ling
paragl'llpbe (Dlrger, 19S).).

'lbe" are Mthods tor introducing the alk71 radicala dtrec\l7 into
barb!. tunc acid ring .. Ul1.t8tl"ated below (Burgel", 1951):

..

The tb10barbl turatee

are prepared when thiourea, 1a condenled wi\b

eth71 malonic acid ester (Adrian1, 19U2)r

/NH~H'"

CS

C';H:OoC,CR

........
....L...............
....... -.- ...••.• -....

'NH;H C~H,,~ doc
\.....

• ......

3

••••!

H

0

/N-C,

--")oC5
l..

/C£:)
''\1.

'N-C
~
0

1be subat1tut1on8 on n1tJ:rogen are done using tHM'th7laul..tate tor
meth71atlon or d1etb71eultate tor eth7lation ot the S,S-d1eubati t.uted barbituric acid (Bush .and Butler, 1937).

For Introduction of other radioals

epecID methode have been deYeloped. (Hen.. and Spurlock, 19L1).
Use of the &baYe de8cribed methode of a1l1tha1a or their modi1'1eat1ona
has made preparation of a very large nUJllber of barbitunt.ea poaaible.

JUrth.fIo

more, a vutev ot pba.cologloal eft.eu &reproduced 'b7 dltterent substituted groups depending on whether t.l-te)" are straight, branched, unaaturated or

O7011c in their charGeter.

1htee facta Mke the consideration of chemical.

atNcture and acUrlV NlaUcme rather oomplex.
(2)

Substitutions on Carbon Fin and PhaJomacological Action.

,t1tIulat1ng ActIo!1-

Moat 1iOric: on the llOd1t1eatlon of the barbltur:l.c

acid llIOleoule bas been done b7 chanrmg the aum.tituent. on carbon tift.

'lb.

characteristio hypnoUc pharmacological action . . . . to depend on the double
substitution because the un8ubetltuted or JtOnollubstttuted barbituric acids do

not have any 8ignif'1cmlt hypnotic action.
tion of hy'dro:x;yl,

etho~l,

•
Shonle (l93l) stated that introduc-

e8l"barql, amino or cs.rboql groupe into one of' tbe

alkyl groups either dest.ro)"s the tvJmotic effect of' the disubetltuted barbituric acid or creates convulsive activit,._

ReplacIng one of the alkyl group.

by' some physiologically active group, e.g. acetone, ether, reeults in inert

col'!'lpOUnds.

lhe introrluetiODof am1.'\o, n1 tl'O or byd1'OlO'l groupe in the pbenyl

radical of $,S"'phe:nylethy'l barb! tune acid causes loss of ·nctiY1ty.
or chlorine increase the toxiet V..

The introduction of tho special groups,

e.g. beneyl radical, into' carbon 1'1''9'9 (Dox and yOties, 1m;

Zlooty, 19ltl) results in convulsive compoundl.
(~honlet1931)

Bl'Omine

Fol"ntSrly 1 t

Blieke and
tiM

thO'.lght

that compounds vi th highly :reactive g1"Oupe on carbon tive were

responsible for the conw1s1ft character.

nowever, now we have numerous de-

p:res!.d.ve barbituratea1ftich oonta1n very reactive groupe, e.g. allyl, on
carbon tive.

Knoorel (19J,6) va of the opinion that the introduction of the

double bond into a brancbed ohain

vulsive properties.

For eDIIIPle,

11M

anbt>Ortant factor eau&ing the con ...

5,5- (l,J-dimethylpentyl) or 5,5-(1,L-di-

methylptmtyl) ethyl barb1 tur1c acid are depressant whUe the unsaturated

analogs oE the $,5-C21ethylpropyl) meth8.l.ly'l barbiturio acid or S,$-(l-ethyl...
butTl) ethyl barbituric acld have proved to be eonvulaive.

to note that

t~!e

It i.8 interesting

introduction ot the double bond into $,$-(1,3-dimetllylbut:;1)

01:1171 barbtturto acid do.. not inC!"ease its cOllvulsive potency.

Velluz (l95la.i

described a senes ot the stl!'1'1Ul.ant barbi tun tee whioh oan be 8Ul11!!arized in
the following table, in decreasing order ot the COl1wleive po tenc7'

llBLE I

R

<

>=CH- CH 2-

~H3... c -

PH 3"

I

<
~lelluz

C2HS

H01 3-

Id.,

H-

Id.,

Id.,

CH3 -

Id.,

Id.,

C2H, -

at;-

Id.,

°6H,-

H-

>=ca-

CHi"

n"

Id. ,

CH-CH 2-

CH3'c

R'

ctI 2-

00- 002>=CH-OH2 -

(l9$la.) showed that analogues

S,'. . (l,)-d1Methylbut,yl)

etn;yl

barbituric acid were depressant when 1,J...diMeth)rlbutyl vas eharwed by the·
following radlcalet CH3- CH2"'C~ CH{r'H3 ) .... CH3-~-eH(m~)r.l~-CH(CH3)-'
CH3-CH(CH3) ... C~-CH2CH(CH3)""

CH3-CH(CH3 )-Clt2-OH2'.

'lhe analogue of $,5-diallyl

barbi turie acid as S,$-dtmethylallyl barbituric acid proved to be stimulant
where. S,,-al17L"Iethylallyl barb! tune acid proved to be deprt.'Ssant.
Frtml the above examples one might say that the presence of

bond in a branched chain or chain coutal.n1ng cyclic !'&dicals is an

the

double

L~rtant

.

condition in order to produce stimulating properUea.
on carbon f1ve has to be considered.

6

But the other mUie ..l

The .following table above the barbi-

turic acids containing the (C.H3 )2. ~·CH-CH2" group can be depressive depending

on the nature of the second substituent.
of the degree of the preanesthetic

1he compounds are listed in orda!'

~ tatory

and hypnotic potenO;Yll

TABLE II

R'

ft
~3- O=CH-cH2-

PHj

.

01: Dtc1 ta. tion
Betore Aneethesia

LJegl"8e

+ +-+

OH3- O..CH-OH 2-

CHi

+ +

Id.,

C61IS-CH2-

Iel. ,

N.C4~-

+

Id.,

Seo. C4!~-

+-

XeL,

~H5-

0

Id.,

C6~!

0

one can uk at this poin t of the
s~ating

conditiona.

co'l'lTpOUnds might be ueed

a.El

d1.c:ru~a1on

analeptic

1Ihether or not these

~ente

in various depressive

The a11thor 18 not aware of any clinical trials or this po8sibi11

tl", but 81'11-.1 experi'!Yl4!!nts indlcate that these compounds can antagonize aome
depressive atates.

Knoetel (19)6) reported the stJ.mu.1ating potenq' of S,$

--

1
(1,J-dimGthy1butyl) ethyl barbiturio acid 1n ~ts abiliv to stimulate the
reflex acti.on
oB thetised

ot the

M. tibialis in spinal dog preparations or in dogs an...

vi til barbital.

It proved to be l/2S0th. ae active ae s try'Clmine

and IJ4th u active as pieritoxin, resG'"!hling the tirst'more than the second
in its 8ppal"ent site ot action.

caffeine, oocaine, or ephedrine.

compound is 'Very coovulaive :in
blooded aniala.
dose

ot

It prodtlced more st1mul.ant ettecta than
Swanson and Chen (1939) shoved that this

V&rr!I

blooded animala whU. depressant in cold

Premedication li7 a dep:rusive barbiturate raised the lethal

this eDmpound a .fewtold but p!"tmledication w1 til it did not raise the

lethal dos. ot a depressive barbiturate.

One can eonelude that theroe is no

.ltual an tagonism between these compounds.

Knoerel (191,5).

-

--&1.,

In vitro studi€:'3 by Fuhman et

thill compound attected brain respiration in

arbiturates.

SWanson '" tincl.:1nga were confirmed

--al.,

B&llem 8t

(19M) showed that

the same way as common depressant

(19M3) Obs81'9'ed that S,S-(J,3-di'I'lletl'lylallyl)

tIl,.1 barbi tur1c acid cause..... tlessnes8 in doge and an increased gastric

eOl"etion through the parasympathetic syetem.

Noble (19L9) towld that

$,5-

l,3-d1methylbutenyl) eth71 barbituric aaid increases gastric secretion but
. iniatration of pentobarbital abolished thie etfect.

Tqlor and Noble (1949)

."ined the pharmacological properties ot S,S-( 3,3-d1llethylally1) ethyl
1OI!LPf).i tul"ie acid t!ndiJlfr, that it increased the blood. pressure. rate and depth

t res:pira tion, bod,y temperature,
bon deseribed 8~.

and that pentoba!bi tal could prevent the

Velluz (19Slb) using S,S(lf~-qolopentamethylaneall,yJ)

th7l barbituric aoid showed its respiratory stimulnting action in uretheni ..d
abbi t.

In comparison wi til eafteine 1. t was more potent and taster aoting.

r
!

smallest MAD and shortest. duration of action.

9
•
'!he effect. of the change in

position of the methyl radical is such that the .normal pent)"l derivative has

the largest 'MAD and longest duration of action.
Karlier workers have reb. ted this increased effectiveness of the seebu tyl and sec-amyl groups to the prosen ce of groups having optical. activi t:y.

:towevel", there is experimental proof that au ch enhanced activity does not
depend on the presence of suob. groups (Shonle, 1931>'lb.. brmohed derivattfts such as 5,S"'propylmethyl,('arbanyletbyl barbi-

turic acid or 5,S-diethylcarba.nylethyl barb1 tune acid have approximately
equal degrees of effectiveness.

'!he 5,5-cyclopentylethyl barbituric acid con-

taining a cyelic secondary group, has the actiVity resembling that of the
pri.lfIary series rather than that

ot the secondary series (Shonle, 19.31).

It an at.hy1 ~cu:p (Shonle, 19.31) is replaced by a larger group, e.g.

prop,yl, the hypnotic effectivenees is reduced.

S,S-sec-butyl n-propyl barbi-

turic aoid has less bJpnot1c action than >,5-sec-bu\Vlethyl barbituric acid.

Tbe fomer has the

IHlM

molecular welght as the S,S-sec-amyletby1 barbit.urio

acid but t.his compound has the greater hypnotic poteS1C7-

These ezamp1ea il-

lustrate that bot.h molecular weight and the iIIOfl'lfU"io stJ'llcture ot al.lql Bub8U tuents are important fao'WZ'II in detem1ning the Phll.J"m&cologieal propert1ae.

When the ethyl group 18 replaced by an allyl group certain differences
are observed (Shanle. 19)1).

In the primal'7 asnes the l!JJaXiJImm h1Pnotio et..

tioac:y and toxic1ty lie betveen the propyl and butyl groups.

In tM eeoondar"J

serios the sa_ ma.xi1'll1ll'! lif!'8 between the bu~l and the amyl g1'OU!'s.

paring the an71 f;roups

1)1

COI!-

ot this series the iaop.l"ima.r.y is considerably more

10
•
pri~&r7

c,yclopenty1 18 1Il0re effective

theBe or seeoll.dary eyc~nty1.

In the S,S-alk:ylallyl barbi-

effecti". tLan the primar.y whereas the
than elther

ot

turic acid series wi t.h increasinc molecular weight the therapeutic ratio increasee to a. l'IVIXi.muM of aoout 2.$ and V.n generally dropa.
usually

increa.st~S

Unsaturation

the effeotiver1*:138 provided the two substituted groupe have

like nUl'l'lber ot carbon atome, e.g. S,S-s8c-butyla1l.yl barbituric acid shows
increased effecti.veness and tOXicity.

Silonle and Waldo (1933) prepared un-

saturated derivatives of ,,$-eec-butylethyl and 5,S-he:xylethyl bubi tur1c
acids.

'lhasa cortpounds in 8M&l1 doses produced ronwlsione arId even in higher

dosos {taft poor anesthesia.

'lbe to::d.ei t7 increases with greater molecular

weight and with increuing degree ot unsaturat1on..

Cope

am Hancock (1939)

indicated that the unsaturated radical and alkyl barbituric acids e.g.

propenyl. alkyl or dial.lqlvin71 alkyl conrpounds tollow

app~tely

i80-

the lame

rules of effectiveness ~.e., the maxi!!rutll of effioacy- is reached With butTl and

am,;yl der-lvatives.

'!his generalisation is in tail' agreement with Shonle"

statef\1ents (Sbonle, 1931).
At the end or the discuesion of the suhat! tution on carbon five a
new class of barbituric acid derivatives, the sp1robarbitUl"ates should be

mentioneQ.

'lhese compounds are structures in which the carbon five at.om i.

a constituent ot both the barbiturate ring and 'th.e substituted group, also a

- -&1.,

ring structure (Cope et.

19h9).

'lbese COl'l1pounds an an exception to the

rulE' that replacement of both valences at C five by one group gives inactive
compounds.
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SUbati tutions have been made in this group of compounds on carbons

3'

'I'

6'.

In the series with a double bond betwem carbons J' and

ht the

hypnotic and toxic properties increase vi th increasing 1ftOlecular weight.
c~und

Tbe

vith optimum therapeutic tndex is the 6' isopl'Op)"l or propyl deriva-

tive.
'Before concluding this discu8Sion, the .findings by Butler and Bu8h

(191J2) are worth mentioning.

'lhe:J.r series of barbituriC acid derivat:lYee con-

tained tJlo lonEl: chains on carbon five ginng comparativelT effective short

acting barbIturates.

on the basis or their findings they concluded that the

old g8leralizations on the structure and activity relationship should 'be
accepted vi th caution because this new series does not con ton to older rules

set by ppevioua wo rkel"8.

en

Substi tutione on ~i trogen and Pharmacological Action.

Dox and Hjort (1927) reported that the introduction
~ups on nitrogen one in S,S-dialkyl barb! tunc acid tailed

action of the parent compound.

ot the alkyl
to enhance the

'Itte introduction of the meth;y.l and ethyl

groupe shortened the induction period and duration of anesthesia while increas-

ing the 'MAn in I'I!JOst cases.
ttvea of

SWanson (1936) obaened that the ?f-ethyl deriva-

S,$ ...dialkyl barb! tunc acid required larger doses for anesthesia than

did the methyl derivative.

Tabem and "olviller (19)6) -described the phama-

eologieal properties or. N-subetituted barbituric acida in

80J'!t8

detail stating

that the hypnotic effect co• • ver:f rapidly (the animal 1s asleep with the
c:.Km'Ipletion

at irtjection) lI'ld the recovery is fast.

In general the most satie-

12
factory compounds are secured when one group on carbon t1ve is secondary the
'he attach:mfmt ot

other is Mthyl and the nitrogen 8ubsti tuent i8 meth71.

large pri"llary, secondary or tertiary Vroupe on N one leads to compounds of low
hypnotiC value.

The same findings were reported by Shome and Doran (1936),

--al.,

Tabern and Vol.iller (1936>.. and Buck et

(19)e).

:there 18 some indicatior

that. tV alk,yl derivatives can increase the convulsive p1"Operti. of barbituric

acids cont&in:1ng six to Beven carbon atoms on the fif'th position..

In this

respect, S-,-(l,J-dimethylbutyl) methyl barbituric acid can be given in dosage
of 170

",,/kg without

pl"Odaction of convulsions whUe ita N-meth71 and ethT1

der1vatifts produce convuleions in the range ot

7-15

Jttg/kg.

Henae and

Spurlook (19L1) prepared a eeries of N...aubatituted phenobarbital derivatives

attaching the follOWing groupe: preplonyl, IB-hydl'Oxyethyl,
phen¥l-phenacyl, J)henec)"l, p-b1"O!'!tophenaeyl.

The majority

showed 8i ther very weak or no hypnotic activit)r but at

strated increased anti-convulsive p1"O!'ttrties.
N-C}{ COOC2HS'

~chloroe'th71,

ot theee cO!I1pOUnde

the sa-me time demon...

Sandberg (1949) prepared

S,S-aJJcylal171 barbtturic acids, finding that they weN ultra

short active ..
'Rush and Butler (19)7) propnred a series of tetJ"aJllkyl barbi turio
acid (dimethyl barbital, -lpraI, -dial, etc.) and noted the following proper-

ties t

they wore short lasting and fut acting and requ1red 8""8l.1er d08es than

did tt18 parant cOIIIpOftnds.

Their nction varied f'l'tIm pure bJpnollia e.g., 1,)-

dimethyl 5,S-dim.et1"1' barbituriC aeid to pure convulsive eftect e.g., 1,3-

dimeth,.l, $,S-dlallyl barbituric acid.

Sandberg (19$1) stated that the hyp-

•
notic action is probably based on the free hydrogen present in the barbituric
acid which, he believes, could interact with protoplasm.

According to him,

the di-ni trogen substituted barb! tunc acid should be ina.ctive.
1,.3-CIU"bo~thyl,

He prepared

5,5-di&117l barbituric acid which did not t;'lhow any hypnotic

properties whereas its m0l101ubstltuted analogue wu fl1pnotic.

1he difterence

between these ruults arri those of 'Bush and Butler (1937) could be explained,
aCf'Ording to Sandberg, b7 virtue o·f the fact that the N-dil'leth71 compound used
by Bush could act as the dellteth.7lated product.

F.!Ven so the anthor doubta

seriously that the obserftd fast action of this group ot OOl'!lpOUnds could be
po8alble it aome metabo.llo processes are required beforo they aro aotive.
(h)

Substi tutiona on Carbon 7Wo

ina

Phamaco1og1eal.

Action.

'1'abem and Valwiller (193$) reported that the

thiab&rbltu!"ic a.cids

proved to be tuter and shorter acting than the parent compounds.

to

~an.Oll

!l !!,.,

According

(1916) the sulfur analogues of barbituric acid otten in-

duced P1'8- and postanesthetic tremors, convulsions, or even convulsions alone
wi thou t

Pl"oduci~ Clt:tS thesia..

Even

80

the

SllJ"V'iVal

time vu shortened if con-

wlsant thiobarbi turate was admintstered along wi tb the lethal dose

or

a

c0m-

mon depressive barb! tun te.

A different t)tpe ot barbiturate acid de!"ivative 18 represented by the
recently introduced ant1eonwlaant dru.g myaoline which has a fully

p;rr1,mldlne r:tng - carbon two contains two

oxygen. atom.

hydro~en

8a.turat~ed

atoms instead at the usual

'Ibis drug proved to be a strong anticonvulsive and weak ·h1Pn0tie

r-.

I

The sarno C'lOt!!pound 1ndieat88 that no freE! H ions are
eological actin V of the barbiturates.
(S)

neeos~;ar;y

for the pharma.-

(Sexton, 19$.3).

The Relation Bev,f€et1 Hypnotic and Anti-

donwlsant ActiviV.
'lbe previous dlscuE=sion dealt mainl". w1. th the
and hypnotic actin ty.

rea tion

of structure

There are few reports which have tried to relate the

hypnotic and anticonvulsive actiYi ties_
FYerett and Ritbard (19L5) showed that S.S-d1meth7l barbi tunc acid
had neither h;ypnotic nor anticonvu.l&a.nt actirt V whereas 1,S,S-t:r:!.Jtetbyl
barbiturio acid proved to 'be hi.gIll)' antieonvul.8ant Without any sedative 8ide

effects (?<fAD over 1 gM/lcg). 'With I-meth,yl, S,S-meth,yletby'l barbituric 8.e1d
the hypnc,tio properties were not evident and it wu still effective as an anti-

convulsant without sooation.

lb. l-methyl, ,S,S-d1ethTl barbituric •.cid wu a

!'!lOre powertul h1Pnotic but it va also an effective antieonwlsant in dos.
producing ata:x1a.

S,$-dierovl barbituric acid was a eentNl convulsant and

.

also an antieonvulsant against metralc!.

:the higher saturated aliphatic com-

pounds showed powerful hypnotic properties but relatival7 poor ant.1convulslll'tt

aet1'f'1v enm in doeu causing sedati.on and ataxia.

Cohen (19h6) described a

series of $,S-alkyl th10etner barbituric acids with just the opposite findings

to those of rverett.

He found that the

1nc~e

in the mtieonvuleant acth1. t7

was direct proportional, in this group ot oompounds, to the nUJ!llber ot the carbon a't'.m.ss in the side crain.

Allee

!l!!.,

(19h7) stated that the anticonvulsa'l t aetion of a drug

~istance

mq !nvoln a mechanism which increasee the

t.owarda irradiation of

motor discharges and does not necel:l<sarily involve depression of higher ne".
centers.

His findirlp's supported this view.

S,S-phenylbut;yl barbituric acid

showed only one third ot the hypnotic activiv ot S,S-pbenylethyl barbituric
acid but the first substance i8 superior in its anticonvulsant activiV.

That

the basic struct.ural mechanisms for the anticonvulsant and hypnotio action are
not idf.mt:lcal or interdependant i8 Ulw;tr&ted by tho simultanaows presenCE! of
~ot:te

tbe

and stiMUlating properties ot !>,5-bt:,naylethyl barb! tunc acid..

'lb. presence ot Olle phenyl group iEl necessary in $,S, disubetituted barbituric
acids for t.he 8t1tlcvmsulsive properties but tho presence of dcuble phenyl

[grOUPS

C&Uf!!.

convulsive activi q.

convulsant. aCtiVity in the

'lhere

--al..,

apparently a maximum of this anti...

S.S-pheny1bu~1 bl!U'bitllJ'ic acid

lihUe t.he branohinge

In a stud;r ot the analogues of the unaatur-

'rJt ttw Ivaight chain decrease it.

rtted serJ.es (Alles et

i8

1949) it

"'''1All

round that the W'lsaturation did not

ute1" the anticonvulsant aotiv1\7 but the hypnotic and lethal actirtU.

'Wel"e

reduced.
(6)

The RelativltT of the Stimulantt and Depress!ve Actions

t Barbiturates.
Tn discussing the depressive and comul81ve barbiturates one has to be
'8%)'

earetul in eftect.mg ll.I"oper usage of these terms.

fnd Cben (1939) .. Fuhman

!! !i_I

(191.1) .. Knoete1, (191t5), i\idlard (19Sl), that

beee propert1(;'. are relatlve and depend in
~g

and the apecies ueed.

It was shown by' Swanson

SWanson

inC;'

80Dle

degree on the me1:bod ot test-

Chen (1939) confimed findingS ot

}rt0efel (1936) that S,5-(1,J-diMetllylbuty'1) etJl;yl barbituric acid is convulsive

r

.
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in warm blooded animals, but be showed in addition that it is depressi" in

cold blooded alimals and gives an adclitive effect to the lethal! tv of 81'!\Ytal
in yam blooded animale.

--al..,

furtherMOre, Fuhrman et

.

(19!U.) pl"O'V"ed that it

is able to depress brain oxygen uptake, as the COl'l'I."lOn depressive barbituJ'at,8a
do~

Knoetel (191,:S) OO"lJ'ared the 4etion o.f' dU"f'erent barbiturates on the

spinal dog and the :tn tact an1.ma1,.

He found a similar! t:r in the stit!l1lAting

action in both Mimal preparations "'lith S,,-(l.. 3-d1methylbutyl) ethyl barbi-

turie acid and ",-(l,3-dimethylbutenyl) '!I'Iethyl barbiturie acid.
while

,,5..(1

FWn so,

ethylbutenyl) ethyl barbituric acid and S,,-(l ethylbutyl) ethyl

barbituric acid were cOn"IUlsi". tn rats .. thes., compounds did not markedlT at-

feet the flexor reflex in the dog.

'lbe thlobarbittuoates ar€ .trequently stbtil-

lating while the bO!!tOlogolls ox;:ygen barbiturates are deprusi".JI bu,t when the
omen derivative 1s already highly stimulant e.g. $,5-(1,J-dimethylbut;yl)
etbyl barb! t~lrl (! IJoid the au'b8t1 tution

ot sulfur on carbon two abolishes the

st1T1JUlating action in spinal dogs 'While presening it in the intact animal.

Richards (1951) studied the convulsive thioba.rb1 turates in three different
speciest

T!IO\lSe, rabbit, and !'IO!'lke;y.

.

He found that rabbits have the great.est

tendency to re&et eonvu.lsively, mice seoond, and l'lOnkeys the least.
majority of"

th~e

A gr'(;at

c01'l1pOtmds although convulsive in rabbits wore h)'pnotic in

monkeys a'1o the results wi th metl'asol in mouse protection tests where subcon-

vulsive doses of: t.h1obarbiturates ga.w protection against metrasol convulsions,
1f~re

in good agreement ,.,tt th "su1ts in monkeys.

!t foll0W'8 that all of" the

th1obarbituroatea investigated poseeased some sedative properties wbich would
not be obvious it only certain species or methods would have been applied.

"..-

I
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Even the compounds causing convulsion in monkeys produced sedation if premedication with small subhypnotic doses of pentobarbital or morphine were used.
'Ibis proves that certain "convulsant" thiobarbiturates also possessed a
hypnotic property.
B.

Methods for Study of the Anticonvulsant ActiTity'.

'!be followlng discussion will give an account of the methods of
sCl"e9ning po ten tial anticonvulsive drugs.

bse tests can be divided con-

veniently into the fbllOWing groups - (1) electrical stiimulation methods, (2)
pharmacological. stimulation methods,

0)

experimentally induced stimulation

foci.
(1) Electrical Stimulation Methods.
The following historical discussion is based upon that given
Toman and Goodman (1948).

hT

lhe first attempts to study the drug effect

hT

electrical stimulation were those by Arbertoni in 1882 and Bilaeles and
Zbysaewski in 1914 who used faradic stimulation of the cerebral cortex through
the trephined skull emplOying a relatively prolonged stimulation of thirty
seconds.

Schiff in 1922 adopted JelUnek's (1920) method using corneal eleo-

trades and measuring the seisure threshold for &1. ternating currant applied· for

o.s second.

Spiegel (19.37) also used corneal electrodes but measured thres-

hold with both time and
ampere - seconds.

intensi~

as variables expressing the threshold in

Merritt and Putnam (19.37 and 1938) applied rec·tB.ngular

pulses of direct current for 10 seconds through skull and mouth electrodes.
Alles ~
~o

!!.,

(1947 and 1949) employ-ed alternating current of fixed strength

that shock duration rather than current strength was employed in their

•
determination of threshold.
C'!!l!"'J"'ent

18

Barany and S tein-,Jensen (1946) passed al. temat1ng

throur,h the electrodes placed in the extemal auditol"7 meatus and in

eontl'Ut to previous wrkel'8 detemlned the erfects ot drugs on seisure
hold for both long and short pel"1.* of stit'llllation.

thrt~

In additiDn they ob-

served the effect ot the drug on 8f1izure pattern as well upon aeiau1"e threehold.

Taman, Bwtnyard and OOodman (191",6) also directed attention to the

effects ot the antieonvule8'lt agents upon se!sure pattem e1iei.ted by supramaximal shookS md introduoed an assay' t'Ilethod based on their ob3ervatione.

Clinically established anticonvulsants (dUantin, phenobarbital) have in
COlI!!!!On

the abUt t)" to aboUab the toni c extensor

seizure is pZ'oduced by eupram.ax1ul shock.

COMponent

it a max1mal

1b1a property is particularly

significant with respect to dl1antin which is ineffective in al ter.1ng the
no mal electroshock threshold or in protecting against the usual convulsive
do~e of metruol.

'lbe results, therefore, suggest the poBBibility that the

efficacy 0.1' clin'Teally etteeti'l1'e epileptic agent ma,;r be better eorrelated with
a reduction in abilit)r

ot the brain t.o

support selt SUflta1ning discnargea than

wlth a simple inel'P..... 1n tbe electrical and chemical threshold tor initiation
of suob disehargee.

In addl. tlon, not all investigatoN are as-reed that

electric shock seisure threshold in epileptics is abnorYllall.y low.
and Kennedy, 19113).

(Kalinowsk;y

Toman, Loew. and l100dman (l9h7) exter:~dod this method by

studies on the «".etten ot druga on the seiaUl"e patt.ern in nomltpileptic psychoti
human patients tmdergolng electroshock therapy_

It

W88

observed and confirmed

that the prttients p~dieated 'Wi th dil.antin have a greater than normal in ...

cidence of atypical sell1ul"'U.

• 19
There was shortening or even aboli td.on of the

tonic phnse ot seizure by dilant1n end mesantoin.
criticized

t1H~

Toman and ("JOodman (l9la)

oririnal Putnam. and "!ern tt Mthod for detem1niny'

thr~hold

ot minLlIlal seizures because of the long period of stimula.tion used. In

trying

to dup1.icate exactly their l"88u\ts they round that dilantin effectively shortened the l'I'I.8X1mal duration of seiaure produeed by prolonged stblulaticn eo that
tonic clonic activities ha'ft ended before the stimulus was t)ver.

'.£heretoN,

they used brief shoeks (0.2 aeeond) in order to permit observation

throughout their entire course.

l"urt.~ez-ore,

character or seillures the,. tou.nd it 1.8

ot seizures

since a drug MAl' a.l ter the

1~r'tat'lt

to take as a threshold rea-

ponse the minimal. selzurea (tooal and li!1'lb clonus).

SWinyard, Toman and

Goodman (19116) introduced the techn1que ot artificial lowering of seizure
threahold

b7 hydration ot apertmental anillals

action of antieonvulaant d1"'Ug8.

in order to stuc.tf the pl"Otectlv.

'Ihls method was of particular interest becaUE!4

dilantin vas able to raiBe the convu.l.sift threahold in such an animal.

',roru.,n

(1951': described a new technique ot etiJ!'IUlation using a current ot low tNquenq.

W1th lower trequenq (e.g. 9 msec rectangular puloo., five to six per

second) it beC&1'l\e increuing17 dU'ficult to produce seillures having a tonic

phase.
seizure.

'!here was littl@ evidence of. nelll"Ologieal depre3sion euring clonic
The tHtl.urea weN usually lim! ted to the tAce and

altemating allwmatiam resembling

th~

pal'chomotor a.ttack.

fore~t,

;,t was

allowing

E'Uq"Alcted

tha t. this might be a s1»oU'10 test for the pot-ential anti ...ps;rchomo·t.or drugs_

Tverett and TOl'f1&l.1 (19,1) found that

ph~:,;nurone

'Was verjl' orrectJ:v(l in raising

the threshold w.l. tbout any deoref3sive s.ide effects.

rYerett and Richards (19$2
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were able to show that phenurone was not onl,y able to rau.e the threshold
but also

to

modif.y the usual pattem of eeiSUN.

Goodman, lOman and Swtnyard

(191.&6) tried to correlate the antiepi1eptic action ot the drug wi th ita abili.

ty to aboliah the <onwaold activity ot brain but were net sucoollsfUl.

Tr1dione and phenebarbi tal raised the threshold ot current necessary to produce El'O convul81ye pattern but prevented H:(} discharges only in toxic doses.
Hhle1don and van Hanevelcl (19$1) could not find

811'1'

eftect on conwaoid act!-

vlty for trld10ne whereas phenobarbital. vas quite effective.

They concluded

that the lack ot such correlation may be indicative ot a diffeNlce between
convulBoid activity and the EF(l equivalent ot the epUeptio seizure in spite

ot

the other apparent resemblance.

The only

!2. _vi_tro
........ l"'l6thod

developed to

test antiepileptie activity ot a dru.g is on the sciatio nerve preparation of
the frog.

('Ibman and Hendley, 1941:).

'lb. effect ot a drug 'Was deten1ned on

the excitability', action potential, ooruhction velooity, et.c.

It was found

that dilanUn prevented the appearance of double action potentials atter excessive stbtulaUon.

But it. 'Was w1:bbout any effect on the throshold of the

stimulus whereas other drup such as mebaral., phenu,ronet mesantoin had this

effeot in addition to the first one.
ReCOl'!ll'ltendati.on.a uaetul. in planning slJoh experi.ments are tound in

--al.,

articl_ by 'lbMn and Goodman (1941), Ewinyard (19k9), S1t'inyard et
'Wood.bur,y and Davenport (19$2) ..
(2)

(19S2)

Pharmacological Stimulation t.(ethods.

'1bman md Ooodrttan (19Ltn gave Aroortoni (llW2) credit for the first
atte~ts

to analyse the effleaC:y ot an anticonvulsant drug (bromide) using

r·

I
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convulsant agEnts.

T..andols 1n 1881 applied creatine to the cerebral cortex

of exper:imental an11!lala in the earliest atteropte to produce local "ei.urea.
Buglioni and !"agnini in 1909 introduced topical application of str;ychn1n••
Before the advent ot metruol auch preparatiorur as t.bujone, homocampin

--

(Lennox et al., 1929), abe1nth (Hlsberg and stookq, 1923), were ueed to produoe convulaione.

But aooording to Putnam and Merritt (1937) these methodS

were va". drastio and. were llla8u1table p1'Ocedurea tor stud;y.lrlg the faotors
which mq ettec\ the ocOUl"l"8nce of the sei.urea in patients.
cOll'VUlNnt

dru.~.

Recent uaage of

in laboratOl7 ustq 113 exemplified in the 1f01"k8 ot EveNtt

and Mobards (1944), Fwrett (1946), ("JOodman and Toman (191.6), 000<i"'l&n, Toman

--al.,
ot

and. S1dnya.rd (19h6), S1dnya.rd (1947), Chen et
The above authors used the aubcutaneous route

(19$1) and. man;, othen.

adm1n1llltrat1on of 7$-90 mg/kg

of _truol, as a result. of which the animals without p1"'8m4!Klication would eonwlee.
giTm

If the premedicated animals failed to haTe sei.ures a second group 1.1

a higher doee ot _tolUOl.

rus

procedure 1IU repeated until the dose

ot metruo11l88 attained whioh produced Wical convulalona. In this

lf8.)"

tJut

tlegree ot protection <_truo1 antagonism> tum1shed b1 a drug in question 'A'l&7
be asoertained.

al.,

-

-

A d.itteNlt. _thod 'U8ing met.ruol vas described 'by Orlott et

(1949) _ere metruo1 waa injected intravenOWllyat a definite rate and

the animal.e were ob.....ed 1I1hUe they "ere being injected.

aeau,.

and

The patt.em of

the death pictures . .re well defined in the untreated alimal grou

eo that. compari.8ooe can 'be Jll.8de with the treated group.

lhe elevation of the

dose ot _tNSOl over the o:mtJ'Ol level required to produce various phases of

22
•
oonvulsions is taken as an indieation of the protective action by a drug.

--&1.,

According t.o Orloff et

(1949) this method presented distinctive advanta;:

over the subcutaneous metruol teet such in that.'. (1) fewer an1mala are required to get signifi(,Ant reeults, (2) leas time is neccs58l7 to cO"ltPlete tea
ing and (3) it is &q\14l :in accuracy to the subcuta.neous method.

will be used in the

--&1., (1953)
et

SCre0.L"ling

'lhle method

work: to be presented in th1e thesis.

introduced a ItMaxi.m&l l~etrazol Seiaure" method.

injeoted intravenously with a .fixed dose

C*rOOdman

The mouse is

at metruol a.."ld observed tor the

appearance and dul"8.ti.on ot convulsions with tonic clonic coPJPOnents.

The

Mouse was considered protected if anticonvulsant drug prevented the appearance

at the hind leg

tonio extenaor component

reeonnnend this method

&8

ot the seieur-e. c.oodman did not

a useful asaq proceaure beoause the lIlort.atH:.y wu

much higher than after maXimal electroshock threshold and it was More dirricul t technically.
The fact that MetraMl in 8ubconwls1:V'e doses is able to produce

characteris tic nn al tara. Mons (8 traus and P..ahm. 19.39 J navis .rmd Sul.bach"
19bo, 'lbman and Davi., 1949) 18 used for assaying the potential of antiepUeptic drugs_

In rabbits. appJ'OX1,."IatelJ' one half of ClOnvul.s1ve dose of reetruol

produoee d:fsrhythmias with

etu.;raat~riHtic

smooth rive-second wavos ccmte.ining

spikes (Iimllar picture ,t4 petit mal. fm).
801su.N8 are heralded by the

appea:,anco~r

If a

lllr~~r

dcs($ if: f.1ven tbe

g:t'01.1pe or high. voltage spikes in

the motor cortex anci is usociated wi th clo!lio:1Kn"9manta whiC'h are f'ollowed
by clinical and FItl tonic clonic Se1&UN.

It

w~s

shown that tr1dlone i8 par-

4

ticu1ar17 e~feotive in prevention ot this abn~mal F.FO picture.
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This tr1dione

speeif1e1 ty 1& well correlated wi til 1 t8 c1inica.l 'Value in petit mal.

On the

other hand the barbiturat. do not mow such a selected actin ty on Ute Ern
pieture (""'an, ooodman and SWinyard. 1946).

'lb. other recent report on pha!'l'l'l&cologteally induced sei&ures 18
that by Anderaon (1949).

He succeeded in producing conwlalona by injeet.1ng

to produce oonvuleiona by

acetone into the cerebral cavit7.

'lbe acetone

dissolving brain lipoid material.

Chenoweth and John (1947) 8TOked FEG d,;rs-

888mB

rbythmiu eiillar to the petit mal pattern by inJection ot fiouroacetate.

'lbeee dJ'arhythmias were inhibited by barbiturates and trldione.

These two

"'I8thods art"! not used in assaying procedures.

en

Expenmentall,y Tnduced ~tiMUl.at1on Foci.

ACCOrding to '[oman and OOOdman (19L8), Speransky in 192,$ introduced

a method or tocal treeainp or one cf'rebral hemisphere to produce epUeptogenic
lesions in dogs.

This method

1fU

later adopted by Keith in 1944.

Kopelotr

and Barzera (19b2) produced chronic brain lesions by inserting linen disea impregnated With immunological and chemical substances.

The blplantation methods

are not widell' used tor assaying antlep11eptic drugs but they are useful for
stud;y ot experimental epUepe7.

Johnson and l.talker (19$2) shoved that the ex-

penmen tal toci have a much lower threshold tor l:;EQ changes induced by metruo1
C.

BiOchemical Aspecta ot Barbi tura'te Action.

~

/

(1) Barbiturate and Ena,me Interaction.
The work

ot Quaatel

and Heathl. (1932) stimulated res(lareh pertaining

to the act.1on

ot barbituratea on enzyme syste!rra.

in gtneral inhibited Oxy'gen uptake

tv

.
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'1bey observed that narcotics

brain and other tusue.

!!!. vitro.

Their

results were oonfimed by' numerous workers (Michaelis and Quaetel, 19h1,

--

nrieg, 19L6, 1947, 19$2, Penky fit 41., 19$0, WEStfall, 1949, 19$1).
'lbere i8 little doubt that one of the poeAib1e ways in which barbiturates produce their pharMacological effect 18 by inbibi tion of the oxidative

processes.

But the question arises as to whether or not -this i8 the chiet

It can be indicated now that there is some experimen tal ev:1.-

Mode of action.
dence which

S:!OWII

that there are other mechanisms ot action.

Orieg (19h6) gave a good historical background ot the work dealing

with en.,. and hJpnot1c interaction reau1 ting in decreased oxygen utiliZAtion
Kellin (1929, 1939, 19110) in h18 elusiea1 work on the cytochrome& found that
b

narcotiee (urei:..llan4 HpeciallT) prevented the oxidation of cytochrome/ by other
compon~ts

of the eytoclll"'OM S78tem.

He suggested that the effect of the

drugs was brought about by the :fbmation
~sed

ot a relatively stable complex cam-

of deby'drogena.se, substrate and cytochl"'Ol'd.

Jovett and Quutel in 1937

u8ing ether, eh1oretone, and enpal found that certain OOncm trations which
marked~

inhibited oxidation of glucose, lactate, and pyruvate had no effect

on the OXidation of succinate and p-phenylenediamine.

of succinate no
by means of

coenZ1l'M~

8u~c1n1c

~inoe

in the Oxidation

are required and hy'drogen is transferred dlrectl¥

dehydrog8n'se to the cytochrome system, the absence ot

the effect by narootics on the oxidation of this substrate indicate. that the
cyt.oehl"'Ollle qatem or tha.t part of it involved in the oxidation of succinate

25
weB

relative].,. resistant to nah a~~ntll.

'these Neults mowed also that. the

deh7dro genuu were relatively ineensi tive to the action ot h7Pnot.1c drugs.

!41,chealis and Quaatel (19hl) narrowed the narcotic sensitive range to the
regions r("precented by 1 ani II below (nreig, 1946):

Narcotic
1nseDlft1va

region

Narcotic
insensitive

region

Narcotic
insensitive
region
It inhibition occurred at I we would expect the accumulation of

the reduced oo.,...e (~ I).

'-'his 1s not tound.

lhe b10eldng 81 tit

would then be at II since we .lcnft that debJdrOgenues am their reactions wi til
cytoohl"Omfts are relatively insen.,l tift to barbiturates.

artGg (19h6) sugeeste

therefore, that the narcot.ics 11&7 aet by attaching to the reduced flavoprotein
cytochrome b (or other 1ntem.ed1at.e) complex.

--al..,

Perukey at

(19$0) tried to

prove that pentobarbital blocked the !lYNvie 4cid oxidase systerll most like17
at the os1dat1.on

ot tvo carbon fra.gment8. He postulated that the critical

sulf'hydry:l groupe in the J)7PU."1ic deh1d1"Ogenase systfn were the barb! turate

~

I

...
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sensitive molt1&e in the ox1dative mechzlism.

a"" Grieg (19$2) could not

repeat. the work by Pensq and,. thorefore, it seems that the present opinion
is '!hat the flavoprotein and cytocllrom linkage is the barbiturate senei Un

--

The Question arisee as to whether one can explain anesthesia in vivo
on a basis of' the results

!!!. v1t~

wherein the depression of'

uUl1u.tion

1'he follONing series of' observations ahov that the in-

vas the chief ttnd1.'"lge

hibition of oxidation Eer !! 18 not an
harbiturate action.

~

ent1re~

satisfactory explanation of

--

(1) The brain f!\etaboliem 1s not depressed ira vivo until

deep lew1s of anesthesia are attained but much !\motional. derpl"8ssion i8 atreadT obso!"led (Bain, 19$2).

(2)

'lbe condUction through ganglia 18 depressed

--al.,

with no change in ox;ygen COJ1a\lJlPtion (Larabee et

barbiturates

!!!. vit~

19)0).

(3) tow doe_ ot

stimxlate o~gen consumption (Weatfall 1949, 19)1).

--- !!!.

(4) '!he convulsive barbiturates inhibit the brain ox1.da11on in 'V'itro (FUh!"!'l!an

!! !!..,

1941).

(5) 'the fif'V per cent ()2 coneumpt1on inhibition doH

vitro

is _eh larger than tile fifV per cent anesthesia dose, which 1& calculated

on USUlllPtion of the equal d1etributton of drug atter adMinistration (Bain,

1952).
One possible e.xplan.atton of the above described phenomena is a postu-

late that an alternating

pathwlr tor glucose oxidation exists

ly concerned with function and which may

biturate action.

~!

conceivably

MON

wh:i.eh is direct-

sensitive to bar-

'!here is sonte evidence for an altema.ting pathway but the

experimental SUbstantiation of this h)'pothseis 18 not ve17 extensive (natn,

1952) •
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Tt is knoNtl that certa:ln chemicals call interfere wi tb the coupling
,rooolin~.

Mid allow oxidatlon to proceed watetull;T in the .«Inse that no

about another pOfJt!1ble site of 4\::tton for barb1t.uro.tea .. na..ly

1nterfer~ue.

,,:th

It has bem

these

eoup11n~

and transferring mechanisms (Ba.1n. 1952).

proved by f~ and nain (19$1) tba t thiQpental. per~ toharbl tal. and amobarbi t.al.
loweNdtb.e phosphate and 0X)'get1 uptake ratlo of' a

respiring on P7Nvate.
tiona whleb had

ep~elnl

tis''nlo preparation

'lhU depresllon vas obtained at the drug ooncentra-

onl.J a Bl1gbt. effeet on 02 uptake and wbieb approsimated those

rec:yt11red tor the 8nft8tb.1a in vivo.

--

At this drug eone«'. t:ra~. on the uptake of

:norganic pbospbatfll vas inhibited 1"01'4' per cent whereas the
showed 0017 ten per cent inhibition.

per cent

or

consumption

¥lhen the upttake of 02 was still at fifty

:1 ta normal control value the

COMPlete17 i.."lblblted.

~

upW~e

of' inorgardo

phos~ 'hate

Tn general the dosos requi.red to prcrduce fitt1 pel" cent

lnhlbi tion of P uptake aN l'IIUcl\ 10\l.'er than thole prodtlc1ng t1!fq POI"

hibition of

~

by the action

uptake.

ot

'.'ihese
pbenOMena

th~:!&e

was

efm t

in-

Ctne cz cunelude that the uncoupl1nr fdteet is caused
drugs on

o~orvnt10n8

en~ S)lStemB

Which are MOre sena! tive than

G')u].d be used tor a p&rt1al Olq)larut1on

ot

the

obsf!'Wd by woattall (19119, 1951) who round that small doe_ or bar-

bi turates at1T1'lUlated ~ uptake. "febb and rlliott. (19!)1) Ot}6(ll""ltf!iQ increased

r--------.
~

g1ycoly'sis did not necessarily' parallel the co~pllng reactiOns.
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McLennan and

:ell:l.ott (1951) dCMOOstrated that oorwentratioDIJ ot barbiturate which inhibited
ihfil pncsphorylat1on si!'ltUltaneotWIy illlPaireti acevlcholine synthesis in brain

which. required high energy

pholJpha:~."

as the energy source tor that synthesis.

'lh:1s \fOrking hypothesis Qr the barbiturate action is not without
critie:1sm.Bain(1952) .u~laed the main pOinte of criticism.
cu.l.t

It 1s difti-

to underst&.T\d in light of this hypothasis why barbiturates do not give

rise to inorganic phosphatee

!e. vivo.

ACCOrding to 'the above tbeor.y dinltro-

F,hetnol l~uld be anesthetic because of its uncoupling ability.

<lust the reverse of thi..

Its action ia

In addition ver"J mqall dose8 of barbiturate st:blu-

lated acetylcholine synthesis and only larger amounts depress (Mc!..enna:n and
BIllott, 1951).
In eO'flcluaion one ca.""'!. say that there is no clear cut explanation of

tile dIfferent effects on nervous function caused. by barbi tllrat..e action based

-

on the availahle in vitro, experimental resulta. Apparently some new mechanisms
should be found before 001"1 could say .anything definite about the relation or

-.

---,--

the in vitro reau1te and experience in vivo.

(2)

'the Role ot Succin~te in Barbiturate Poisoning.

The il'!petU5

tOf'

reaeareh on the analeptic effeets ot lnlCeinate wu

ven by the findings of 'lUutel and Heathle;y (1932).

'.they found that 8ucci-

late oxidation vas not inhibited by barb1turawa in vitro.

---

On the basis ot

se findings Soskin and 'l'aubenhaus (19h3) tested the analeptic properties at

odium rsuccinate, s!lotd..'1g tba.t it was able to shorten the barbiturate anestha:;llt

.
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time and reduee lethality rate, whereae glucose, lactate, and malate were
wi thout any effect comparable to succinate.

Repetition of Soskin's experiments was made by the following workers:
Heyer and l.atven (19144), Finecmnldt et al. , (19LS), Adams and Larson (1950).

HO'ltrever, the efficacy of succinate which they observed vas ot a

le~Fer

dep,ree.

GUCeinJlte was able to shorten the recover,r period from pentothal anestheela.
He expressed the opinion that. there is no doubt about the value of succinate

aa an analeptic in hu.m.an beings_

'in.

first

suece8s~11

clinical trial with

sueei'o.ate was r~ted by Soskin and 'l'aubEmhaue (19tJ).
On the other hand there are repOrte .howing negative result...,.

barbiturate anesthesia.

--

al.,

Oowon at

studies without any positive results.

f.ardy

(1916) conducted ea..""'etul controlled
Shack (19h9), uetnc rabbite, showed

that succinate :In small and large doses did not sherten the duration of anesthesia.

In addition he showed that succinate did not deereufit the blood and

brain tissue levels ot barbiturates and did not aftect the rate of their excre ..
t10n.

'Ihe question meu

8$

to whether or not other CO'IIlpOnftnts ot the inteJ '"'

Nediate carboh1drate metabol1n can affect;. the duration of lIOosthesia..

AdatU

and I..areon (19$0) round that acetate bad even stronger anale'Ot1e effect than
fJu~cinate

whereu citrate prolonged

--

thE! durat.ioo of

anesthesia.

Fumarate

(Canon et al .. , (1916), malonate, j!'lutamate (Beyer and Latven, 1.91.1L.) did not
'
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have 8.l'I7 effect.

Although pyruvate (Westfall, 191,6) did not sborten total

depressive tiM it did daCJ"eaee the depth of depression.

phenomena
"

't<mS

observed b7 LM'IflO!1 .et
..,....

at.,
.......

A very interesting

(1951) who observed that. the injee-

tion of vartous CO~d8 including intemediatB cat'"boh7drate metabol1n
products (sueein1.te too) returned tJI€! a"!i~l t.o sleep

'Idltl'l ~_tWtW eo~irtt"

out

of barbi.t'Urate anesthesia.

'lbe e-.-<rlanations tbr 'the negative results ·0£ succinate analeptio

--al.,

action point out (L~.r'dy at

19h9) t~Hl't the orld9.tion of ttJceinie add

was not couplf~d wi th phosphorylation which is the only known meeha..-"l.ism furnish
ing energy tor animal..

Furcbgott ana Shorr (l9LB) ~tAted tha.t the extra.

oxygen cOM'l:l1ltPt1on in the pr..enco of succina.te was not ca.:pable of tncreas:tng

the rate of the metabolic nroeessee depressed under t,onditlon& of low ~
tension.

In fa.ct the increued 02 ccneu:mption b,. mlcci.yU'l~ depressed the oxi-

dation of normal substrates. \Iebh ~nd rlliott (1951) stated thtd, ellecin~te

inC!"eued the 02 uptake by brain tissue eith(lr in the ,N5tmCS or absence of
pentobarbital but did not suppress the inc'!"ea8cd lactic (~c1d producMon

by the presence of the drug.

eatUl8

'ibey eOl'll"1udeci th$t the~fl studies in 'Vitro in_

1

dicnted the inability of succinate to reYel"afl the barbiturate errect.

'!he

claim that sucoinic acid can furnish nourishMent for a dw~ressed brain 19
contradioted by findings of 'flein and Olsen (1911); succinic acid could not

support bra:tn metabolism in the hypoglycemic sta-t,e.
But there are some biochemical llnd ptlYSlologic.a1 fin dings which sup-

port t."1e role of fJucoinic acid a.s an a."1alf:ptie.

-Wiler ar':d ~)~F\ren (191,~9) fOWl •

.

ful

Em8rg}'"

''!!"ld(:!'' thf!!$e e{'ndUione.

.31

In exPeriments with anesthetized animals,

Heymat\S ""irl tfaeol)s (191~7) ~howed that th.e in~eetion of 8uce1..'late atj.mulnted.

re"lnUon
~ee'1!.

an~ decreased

the dUl"lltion of

,~n.ea

l.1.::'ter l\YPerventilaU.on.

that, the a.ction of ouoe1nate could be a direct effect on the

It

r~fJP1!'at'<)r:f

I

#lpnea ,." not spee:t.fie ror ateeinie ad.~ beealUu!t NanCO.) end butyrate could
f'lvoke the

~Si\me

"rtet"
the prob],M.

arfeete.

rea,'!lnr, 1',ha above review one

i~ ~AHare

of the complexity ot

For thi. reason 80me work vae undertaken in. our laboratory to

obtain Additional 1.nformatiM about this subject.

C!iAP1'J:'R It

S 'lJ. ~ HT OF PROBLFM

'the pr1ne1pal initial

ob<j~et1ve

ot the work done in preparinp this

thesis vas to etud7 pharmacological antagonists ot the Ct'l'ltral. ne"oue system
depression C8uaed by" selected barbi turs. te compounds.
As the :1ntrOOucto17 stl1"'l'8y has indicated, there are several W&18 to
ai'preach the study

ot tbia probl_. It was decided that the author would limit

hiS work to the following aspects:
A.

~tu~

ot the etfect·

that struct.ural change in the n1 trogen

substi tution or the barbiturate molecule would have on barb! turate depres8ion.

B.
virtue

lated

~tud;y

ot agents that might antagonIze barbiturate action by

ot rev('I!'fJing the effects or lowered levels of'metabolism due topCstu-

b10e~!eal

c.

lesions created by barb1 turate pharMaCological action.

~tud7

of the erreeta of. the highly sti:mulant barbiturates on the

depress ion caused by common barb! tUN tea.

Interest in the stud7

ot structural alteration or barbiturate nitro-

gen substituents was engendered in two
p,roup on the n1 trag-en

~~.

Tbe substitution ot an

al~l

ot morphine creat.es al171-nomorphine, a compound

virtually devoid or pha.r'lll&Cological si?l'lilanty to morphine but which exhibitB
a rather specific antQ.gonism tor the phantacolog1.cal action of morphine and i t.E
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derivattves (Unna, 191tJ; Hart, 19L3; Huggins
1~2;

--al.,

Smith et

.!.:;. !!.,

1950; F:ehenhotf

!.1 !!,.,

'1his eompound is now being used in a practical

19$1).

'Planner in the therapeutie revereal of Wlorphine depression.

It was felt that

the investigation ot the effects of analogCtUJ rompounds in the barbiturate
series on barbi tura~...e i11toxl.oatton, should be carried out.

There are indica-

tions in the literature t..'l-tat the substttut10n of larger radicala on the nitro-

gen atom can decrease the hypnotic acUYit1es at barbiturate moleculea (Shonle
and

r.oran,

--

1936. BIlek at al., 1938, Hense and $purlock, 1941)..

It was aleo

reasoned that these eompounds might be studied with a Tiew toward ascertai."'I.iIlg

the efreet of a classical barb! turate an tagonist, such as metra.ol, on the
action ot the altered compounds.

Such studies would throw light on whether

or not the str-J.ctunl alteration had conceivably altered the anticonvulsive
properties of the moleeule also.
Interest in the role of subs tar::ees capable of "by passing" biochtmlical
Metabolic deticiencies postulated to ooeur

&~ing

barbiturate

depreesi~l

was

stiMUlated bT the contraversies, which still eXist" concerning the original
work of ~08kin an.d 1aubenhwa (l9L3).

Ueing succinnte they ware able to

--

demonstrate a barbiturate revereal in rate in vivo.

"!'bey attl"ibuted this to

the fact t.'1at slleei."late oxidat1.on cannot be inhibited by phtU'macologlcal aotion

tnt. eel no effect

of barbiturate. in vitro.
5

--

Hawe'f'er, the NGults of other workers in

by 8ucclna te on barb! tUN te aneathes ia.

ViTO

! t \>1M fel t that it

ould be of interest to in'f'estigate this problem 1'urther in an a tteY!!pt to
clarity some of the contraversial issues involved.

demon-
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Interest in the role ot the stimulating barbiturates as reversing
a~ents

for barbiturate depression vas eti.Mlllated by the reporte of Knoefel

(1936, 194$),
(1951).

SWan80n

and Chen (1939),

Ii,

Noble (19L9), Vellu.

!! !!.,

ot antagonism between the stimulating

'!bey demonstrated the existence

and depressive barbiturates and between
Tn

~lor and

IS ttmulating

barb.! turates and 1'lOrphine.

few of thece cases it was ascertained that tho stimulating barbi turatee

acted syrmrgist1cally with classical bS,l'biturate depression rather than reversing 1 t as would be expe cted.

'lbel"E:ltol.'e, 80me work was undertaken to clarity

further the analeptic value of this class

Cif

compoundS.

CHAPTFR III

A.

Materla18.

'the animals used in all experim8rlts were Webster strain Albino mice

of' both

BU.,

Tndustriee.

weighing 14 to 20 gra.n'l8, obtained from Harlan Small Anintal

They were heal thy in appearance and had no observable physioal

disabili tiea.

They were red Purina Chow diet

!S. _ll...b.-i_tum
......... vi th

tree access to

water and kept in a well ventilated, air conditioned aniTMl room.
aoeli~atl.ed

'lhey were

to the new environmer. t for at le88 t two d8.1B after arM..val ot

ea.ch shiJ)llent bef'o" being used in experiments.

The tood was withdrawn 8ix-

teen to twenty hours before starting any experiments, leaving free aoeess to

water.

'lhese meuures vere taken to assure a more unitOI"l!! absorption :from the

intraperitional

in~jectton

site.

PHYSICAL AND cHi;nrCAL DA'1.l ON -00: COMPOUNDS
SYN'l'fI1\TIZ}D Ul OUR LAflaRA '!my
Dat.a

~. CompOllnd

Mole-

cul.ar

'Wt.

11.
2.
~.

N-A~l

Fomula

or en...

A.nal.v8i8
Founa caleuIa-

N%*

ted N%

·ObS8rved

)!felting
O

H2O
Saluhi-

PoInt C

l~W.

i3arbltal

226

CIlOJ N2H16 11.89 12.$0

77-78

Fool"

N-Allyl
Pbenobarbital

273

~$0.3N2Hl6 10.11 10.27

tX3.-69

Poor

351

C200bN

156-158

Poor

~-PbenAcyl

Pbenobarbi tal

ne

*Pel"tomed by Dr. t. I. Dinguid, st. r..ouls,

Procedure.

3$

8.03

'.to.,

8.00

using 'Miera Kjeldahl

.....

~

TA~LE

IV

I..15 T OF DRUG PRFt;ARAlInl 'iS US:ED

.
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.
coneentra-

tion mg 't

No. frtlg Preparation
"'I. Barbital

C.P.

000

2. Barbital Na U.S.F.

'3.

u.

5,!> \ J, j

41fJ

d1MCt.ny.Lal.L7.L

\izUV'l.

Darbl turic Aeid Na~ til
Metrasol, B1lhuber-Knol.~

'tA'ethoda or Pr~ara1iion
D18eolved in exoess of ':).l.N NaOIl
neutralised \11th Hel distilled
H20 q.s.
Dissolved in appropriate &mo' in t
or d1etUled ~o

250

2
As in 2

As in

500

4;$. N-Allyl Barbital

L{):),

800

A8 in 1

I~.

bOO, 800

As 1n 1

~()O

As in 1

N-AUy1 Ph.mobarb1 tal

*7. N-Phenac;yl Pbenobarb1 tal.

5('0,

8. Pentobarbital Na, Abbott
9. Pl'lClObarb11iaJ. Na,

700,1200,
1500
h40, tt$o

U.~~.P.

10. Sodium Chloride U.S.P.

900
170]

11. Succinic Acid 0.1'.

12. Succinic Acid

13.

SueeiniMide

c.

0.,.

1700,6800

i .•

~alonic Acid C.P.
(b) Succinic Ac':d C.P.

1lt- ea)

15. (aJ Pentobarbital Na

As in 2
As in 2

Prepared by compan7 (Baxter)
..
As in 2

)L;)O

Dissolved in equivalent amount
ot N8OH, distilled H20 q.s.
in ice bath

1700,6800

As in

)000

,31100

Roth acids dissolved together in
eqHivalent aMount or NaoH, dis-

~

tilled H20 q.s.
(b} portion prepared as in lo, (a
portion added, distilled H20 q.s

2

(b) N-AUyl BarbHAl
16. I a? Pen tob4rb1 tal N'a
As in IS
j b) N-All;,:l Phenobarbital
400
11. l a) Pentobarbital Na
100
As in 15
~ b) N-Pben~eyl Pbenobarbi tal lJOO
Note. (1) Drugs marked were syntl'letised in our laboratory.
(2) All drug solutions were pr~pared daily using the
analytical balance and volumetric: 1'laska •

.,00

*
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In 'rable III, compound (3) waB prepared b1 the author using methods
dElscribed by Henze and r'purloek (19Ll).

COI'Ilpounda (1) and (2) were prepared

Proctor.

by T1r. C. D.

The syringes used for injections were I.Of) ml. tuberculin
f!raduated at .01 ml. (B-D Yale 'fubercrulin, Becton Dickson ana Co.).

type,
'lhe s1ze

qr the needles was t,wmty-stt9'eJt gau~ fot" both intrAvenous 8.nd intraperitoneal
The devi.oe for holding th~ mouse during L~travelou. injection eon-

injections.

:,d.sted ot a (!One shaped holder Made of tnL"1eparent p1asUe, at.t.aehed to a

lfM

used to regulaw the injeottol"! '!"ate.

The anf!!Sthetized

l'!I1~e were kept :in a

(1) Anti.convu1.81. . Pttldieth
'1his phase of til.. loW)rk onMiet(ll}O of two parts: (a) determination

the phal'Maoologleal f.ltfeot o.f'

Ott..

ot

:c;yntheld.sed etmpOU.'1d8, (b) dete1'l''li.nattcn of

the a'ltiCOTlwls1veactivi ty 01 our ~ds in comparison w1 ttl the parent
compounde.

(a) ~tem1rmtion of the PhaMaoologieal prfoets on CfiIltral. l~e~tl8 Sl!t.em

t1he animal. wen injeotP-d by the tnt, ravenous l"O'!.1te with th!l new oolltpOUnds and

Ithe results were compared with those obtained ;!n the Identic~'.l way 'Wi til the
parent~.
PhenObarbital.

l'he CDlItpounda used W~"H (1) N-Allyl Barbital, (2) N-Allyl

en W-Phenaeyl Phenobarbital.

(h) P..a.rbital (S) Phenobarbital.

All were in

eoo mg % solution

at the dose US mg/kg.
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.
Pbwobarb1tal

SodiUl Wal

in 880 'IIIg % solutton tbich c01"'r8l!lponded sDpl"OX1J!lately to a 800 mg ~ solution

of drug in the acid state.
was 12;

~/kg.

T'd.b1e IV.

Its dose on the buia of the

dI"Ug in the

acid sta

lb.. methode ot preparation of these so 1ut.1.one are given in

'lbe total doe. per animal was adjusted by varying the volme in-

jected (16 p an1mal reeeiwei 0.2;
the righting reflex vee taken

88

co_. 18

gil -

0.28

00.,

a starting point ot anesthesia.

this the animal was laid on 1te back and the end point

time of reoovery

eto.).

ot the r1&bttng reflex.

'1'be

l08S

ot

Following

ot anesthesia lIU the

'l'lle erteot ot our s1Ylthetlaed com-

pounde on pentobarbital aneeth.,ia was determined in the following 11&7.

In

the cue of test solutions the 100 mg %solution ot Pentoba'rbltal sodium contained 1n add! tion the 1,\00

Pbenobarbi tal or

me •

»...Phetlae;yl

C<m.eentration of N-Allyl Barbital, N-Allyl

Phftllobal"bi.tal.

'the control group reoeived a solu-

tion containing Pentobarbital lodium only.

'lb..e drug solutions were injected

1ntraperl tonea1ly at the following doses:

Pentobarbital sodium 86 1Ig/kg alone

or in combinatton with the other drugs whos. doe_ were ;0 mg/1cg.

lb. total

do•• per animal vas adjusted by val71ng tne W1UMe injected (16 gift animal

recelyedO.20 eo., 18 gm .. O.22S eel.
(b) ~tem1Mtton

or

divided into 1S-17 gm and 18-20 gm weight groups.
~Allyl

'1he animals were

the Antieonvulaant Activi!f:.

'lhe d1"Ug8

(fIT-AUyl Barbital

Phenobarbital, N-PhenaC71 Phenobarbital, Phenobarbital, Barbital) were

administered intraperitoneally at doeu

So

'lho

to 100 mgIkg.

animal was ad.1usted by v8l7ing the volUl'llGS injected (20

p1

total dose per

an1m&l received

I
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0.2$ eo., 18
SiOfh

grrl ...

0.225 cc.).

All ani'ltals ware obeerved tor signs of depres-

A $00 mg % solution of metrasol was used tor intravenous infusion 5,

or 120 Minutes after administration of the test drug.

{fJ
,,<115

lhe rate of infUsion

0.0$ cellO seoonds regulated by observing the stop watch.

ill. reactions

or the mouse to this timed intraverloua intusi,on showed a definite pattem and
lias eimil:;1r to that described by Orloff

!! !!.,

(19L9).

1'he signs of roeactlon

followed each other in a strict sequence as th,g concan tratlon ot metruol
gradually increased in the blood 8tre~.
tm tch" l~red

II;

Wl'lS

:the first ot these W88 the "first

sham Single twitching ot the entire animal body'.

7h1s vas tol...

"r,y shortly by "pseudoconw1sione" - a series ot clonic movemente usual

11 accompanied by an audible squeak.
down under itl body.

Very often the mOllse pulled its head

'1hese "pseudocorn."U1sions" were followed by altemating

clonic mov&Y!ents and resting phaaee.

1he third sign a "persisten convulsion"

appeared at tbe higbest concentration of metruol in blood and was the tinal
end poi!lt of
by

tne injection. It consisted ot tonic flam!" component followed

a usually lethal extensor cOJ!IpOnent.

:"he author modified Orloff's proced-

ure by observing only tt:f':t.rst Mtch" and "persistentconvulSion" symptoms.

This change was made because change. in the threshold of' the "pseudoconvulsionft
followed 'l'8ry closely the changes in ttfirst twitch" thrt2!shold and because the

latter can be observed With greater accuracy than the former.
In determining the eftit":aey' ot the anticonvulsant drugs the eleva-

tions of t,.;'e metnusol 8oluti.on volumes required for elicl tin« "first twi too"
and ":oersist.ent eonwls1on" were taken as cr! teria.

lhe efficacy was expressed
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in the following value, oallecl the protective ratiot

Protectivo Ra ti~

ThrBShold after treatment,

Norma th"rc:shoi<i 01 the corrElfSpond!ng
control weight group

The ability of the drug to modify the character or the eonvu18ione

(2)

The

narb1turate Reversal Studies wI th SUQcinic Acid

and $,SO,.3-Di'msthylallyl) Ethyl Barb! turio Acid.

(a) ~he :R~iturate Re~ersa}

l'y

~

..

Succinic, A.~:ld and its Derlvati"!.•~

In detHminat1.on of the etticaO)" of this class of compounds to re1ferse the
depressive act,lon of Pentobarbital the hypnotic (88 mg/kg) and lethal (lSO or

187 mg/ke:) doeM of the latter were admin1st..ered 1ntra;perl tonSAll.1.

'lbe com-

pounds being tested for antagonbtic effect on pentobarbital were injeoted at,
the indicated doses right at the onset of anosthooia (succinic acid 212 mg/q;
succinie acid 212, IJ24 and 848 mg/kg after neutralization wi th )~aOH, suecin1rtdde 212 and e,lt8 mg/kg, combination of Malonic acid 375 mg/kg and succinic
acid L24 rtJ.ffftg afwr neutralization w:tth Na(lH).
was adjusted by varyin.g the volume injected (20

lS gm .. 0.22$ eo., etc.).
cribed in (1)a.
rate of survival.

1he total dose per mimal
g!I1

animal recelved 0.2$ eo.,

The procedure for determining sleeping ti.M is de.-

'lhe lethality produced by Pentobarbital

"'&8

expressed as the

7he control r,-J"Oup f'("ceived intravenous saline.

A different

approach to tne determination of any "analeptic· action of BtU-cinie acid vas
tried by examining i t.s etfect on the metrazol convulsion threshold.

The doses

or the premedication were e4B mg/kg of' succinic acid (after neutralization)

and 8uceinimide and the oontbination of malonio. and Buccinic acid 37$ mg/kg
l4"ld

1125 mpjkg each (neutralized).

All were adll'dn1Btered tntraperitontally.

'Ihe tnt.ravenous infus :00 of metruol" performed as described in (l)b, followed

in about five minutes.

"lhe controls were animals wtthout premedication.

(b) 'lbe Ana;e~t~c Act~on of ...5,,?O!~-Din!e:th;Yla!lll) '-:t&l

Parbi tunc Acid.

A 2$0

lI'!g

% solution was injected 1ntrawnoIl81;r at rate of

0.05 oe/10 seeonds while making careful ol:'l8ervatl on8 of the

animal.

'lbe done

of 1,0 ~g intravenously of this drttg as a potential Ot"1aleptic was tried
against the duration of' anesthesia and lethal effects ot Pentobarbital at
doses 88 MP'ftg and 188 mg/kg, intraperttoneally..

were the 5a-"'8 as in ~l)a and (2) a.

The dotai.ls of procedure

CHAPTFR IV
RmUL'i'S AND DISCUS!3JON

A.

Anticonvulsive Studies.

(1)

Depressive Properties of the N-Allql Substituted

?a.rbiturate••

'lbe .periments in this section wore designed to detemine any
changes :in hypnotic activity ca.used by substitution on the ni tl"Ogen of the

barbiturate molecule.

Ofiginally, it was hoped that these new eomp01mds 'WOuld

have a reversing effeet on the

depre~sion

ot animals under

convent~onal

barbi-

turates in a way analogo'll8 to n-allyl normorphine antagonism of morphine and
many of its derivativeah

::ttl order tor this analo",. to hold in i tel enUreQr

(a) very little phlll'!'llaeological effect would be e:<peeted to rewlt when the
I'·I-allql eubsti tuted barb! turate. were administered alone, (b) no synergianl

w:uld be obftervab1e bet'Hf'ert the

N-GubGtit~uted

and common barbiturates.

The

experiments designed to teet these two proporties are sumarized in Tables V
and VI.

'lhe results in Table V (page L3) indicate that the t~-f?ubl!!tituted compounds used :tn the study were ohara.etoriaed by (1) ir1(~reased anesthet1.c power,

(2) i:''ll'l'tediate onset
po8tan~sthetic

or

anesthesia, (3) short duration of aneetheel., (l.!.) short

depression.

TABLE V
sr.ErPTNO 'rIME IWTfi'lr'TNATIOn OF N-ALKYL SUII:; TT'IUTFV
BARBI'lURA'l'FS AND THEIR rARlmr coY.POmms
',-.

F'Xp
,10

11.
12.
3.

14.
[$.

or

A"1I"erage TndUC-

DUrat10n

tion 'I1me. in

Animala

~cf1nutee

Anesth8111a
in Minutes

Compound

.
IV
:i:a

No. of

Barbital

125

$

Phenobarbi tal
lW-A.11¥1
BarbiiaJ.
I-Allyl
Phenobarbi tal
N-Pb.enaeyl
Phent)'barb! tal

US

$

See Text

as

S

Immediate

12$

.1

Immediate

21

l2S

$

I_ediate

9

--

None

!'tone

See Text

L

~-

The phenobarbl tal group did flot sholl aIl7 real G.."lesth.wu plcturt\t

the

anll!!1de lost and rega111M tbelr righting rona periodiea111 and exhibited
prolonged depres.ion.

'lb. baPbi tal group va only madera te1y depressed..

'lhasa .n.ndinge with the N'"'8Ubeti tuted compounds were in good general &ereement with the results obtained wUh the sane clas8 of oompounds in the WOft

of rrox and Hjort (1927), 1ahem and Volwiller (1936), Shon1. and

--&1.,

Bush and FJut1er (1937), Btack et

(1938), Sandberg (19L9).

Do2'8ft

(1936)

fO!"te of those

workers showed that the anesthetic power, comp:tred on a basis of minimal
aneathetic dose, was either deoreased or increased.

In the author'. opinion

the route or adrrdnistration ean be an important factor 10 dete:rm.lning the

relatiTe potency ot this elan of new drugs.
(1939) the initial rate

or detoxification

ACCOrding to attler and Bush

of these compounds

~

be futer

tlllW the abeOl'Ption in the cue of

tnt.ravenous route.

routes ot adldniatratlon other than the

'lherefore, the more labile compounds would be !!letaholbed

efore they can reach an etfective coneEn trat:ton the site ot action.
~'!B.Y

help to explain the conflicting reports on the

class of ~un&h

given tntraveoously

rea tty.

'.!'hie idea

potency of this

Secondly, it could explain why N-pbenac;yl phenobarbital
~)roduc.e4

c.omplete anesthesia in the authorts hands whUe

Hen. . and Spu.rloek (19ul) did. not succeed in obtaining the ane.tbbtie effect.

('nleir article did not state eloarly the route

ot ad.'It1n1stration used but one

uld Bum1.. that 1 t wu oral.).

TARLE VI
1Mf: J.<F'r"rrCT OF N-AUn SUBS 'rt1H TfD HARSI'lUPJVI'FB 01' THE
DURA nOtl Qf PFN'IOB.lHtl3t'mL ~l rs '11ffiSIA
EXp

No. of

1M

No

Pentobarb1-

1.

2.*

~. IP Animall

Dura.tion of

Uon 'l"imo in

Ancsthesia

'Minutee

in Minutes

tal Na
Ptmtobarbital
lila
N-All;yl:J;uobi-

88

10

2.$

89

88

10

2.5

IS1

tal

SO
9

2.5

101

10

2.$

82

Pentobarbi).* tal Na
I

N-A.llyl

Pbenobarhi tal

h.*

A'V'erage Inouo-

f\8

50

J)en toba.rb1tal Wa

8e

N-P~:u:.'m.BWl
1~enobru.'b1tal

SO

Notet

In elCpfJrimenta marked .. both drugs were a&ti."11stered
in the same .olut.ion.

'lhe results 1.."1 'lable VI demonstrat.e a potentIating effect of the
N-substltuted compounds a.t dose

a."1csthpsia.

Jbis

dOBO

depreasive effects.

So

mg/kg IP on the duration of pentobarbItal

when administered alone did not have any obsenable

ot varying magnitude!

The POtentiating e.ffect was

barbital ::thowed greatest 8ynergist:.c

depreBs:l.v~

~J.all,.l

action. N-ulyl phenobarbital

was or:ly s lightly synergistic, 'While 1!"'phenacyl phenobarbi t.G.l h&d

~10

effect

fwh:!.ch might be due to its quick deetr.lctioll bai'ors it could l'a:;ach ,;frective

eoneentratton at th6 site ot action).

The d"'gree ot synergism to pentobarb1-

tal was parallel to the rolu.tive al'ltioolivulsive potellC:Y as. shown in. Table VII.

--al., (1947),

as shown by llVerett and R1dl~1"d8 (19LS), Allee at
F4.11s (191..\9).

Alles and

Theee L~vestigatol"8 conduced. a comparative study

ot the h3P-

not1e and anticonvulsive propert1€<S findinf2; tllat increase in the hJrpnotic

power va not always followed by' t.lle

(2).
8

8a.~

increase in the antieonvulsive power

Ant100nwla1ve Properties of the N-Altyl

~~ub...

t1 tu ted Barb! turatea.
The above raeults 1nd:tcated thI.lt our s)'rltbetised COMpOUnds dd not

have 8n7

or

normorphine.

the expected analeptic properties analogous to those

or

N-allyl....

Therefore, it 'Was decided to test their anticonvulsive potency

in c»mpari8fm to that ot the paren t compounds.
obtained in the anticonVUlsive stud;y.

'1'able VII contUll8 the results

As seen tram. TfJ.bl.e VIr the N-a.llyl

barbital shoved distinctly different properties than barbital.

Its initial

r-
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'1l\BLE VII

'!HE ANTICONVur..sIVE POTFNCY OF N-ALKYL SUBS1.TIUTFD
BARBT 'lURA TES IN COMPARISON WI'1H

•

THE PARENT COMPOUNDS
DOse 1lSt.

~
[No Anticonvulsive

Protect- No. ot Persistent Protec- No. ot
tive
an i- Convu1AnisiOna cc. Ratio
ma.ls
mals
Ratio

mg/kg Twitch ive
IP

1. Control, 15-17 Om

cc
0.13

1.0

24

0.L.2

1.00

24

0.16

1.0

24

0.52

1.00

22

50

0.47

2.87

23

0.97

1.87

31

60 min. $0
.
.
f:JJ m.in. 100

0.26

1.62

18

0.66

1.27

20

0.21~

2.08

19

0.60

1.41

19

6. Barbital, 120 min. 100

0.17

1.30

21

0.h6

1.09

23

7. Barbital. $ min.

SO

0.20

1.61

20

0.$8

1.36

20

8. Barb! tal, 60 m.in.

$0

0.27

2.07

19

0.69

1.6b

18

9. Barbital. 120 min.
N-A?-~I_ Pbeno10. barbital. $ min.
N-j 1 l.71 Pheno11. barbital. "' min.
N-Allyl Pheno12. barbital. 60 min.
N-A?-lyl Pheno13. barbltal~ 120 JIlin.
N-PbenaC71 Pheno1h. barbital, 5 min.
N-PhenaC7l. Pheno1$. barbi tal. $ min.
N-PhenacylPheno16. barbital. 60 min.
N-Phenaeyl Pheno17. barbital. 120 min.

$0

0.19

1.h6

22

0.65

1.5S

22

SO

0.23

1.77

19

0.50

1.19

22

100

0.31

2.38

2

0.77

1.86

U

100

0.2S

1.8h

16

0.66

1.$7

21

100

0.16

1.23

19

0.h6

1.10

19

62

0.20

1.$4

lS

0.$7

1.38

17

100

0.18

1.12

19

0.72

1.hO

21

100

0.14

1.07

17

0.44

1.0$

18

100

0.12

0.92

21

0.39

0.93

21

$0

0.22

1.)8

13

0.7$

1.44

18

2.

Cont~l,

N-A11yl
3. Barbital,
N-A1J.yl
h. Barbital,
N-Ally1·
Barbital.

,.

18-20 Om

S min.

N-lllyl

Pheno-

18. barbital, $ min.
Pheno-

0 •.30 2 • .30
1.60
Ih
0.67
17
19. barbital 60 min. SO
Pheno1.8)
17
0.77
19
l20. barbital, 120 min. $0 0.26 2.00
Protective Ratio: 'lhreaho1d atter treatment
N'oi'iiiiI fl'iHisnola 0'1 correspOnding lleignt group (C<Ilttdls

activit,. at the same dose u barbital demons trated a l"fIltarkable antieonwls811t
activity both in raising the protective ratios and mod1.f)ing the pattern ot
the eonwleion.

The tirst twi ten and pseudoconwlaions were markedly ehanged

to the extent that they were ditf'ieul t to obse"e.

The other interesting

finding vas the delq ot death after the development ot the ponsuten t con-

w181ons.

More than halt ot animals shOWed this delay ot death and in some

cases it lasted up to th1rv m1nut€tl.

:Even so the lethal eon'lUl.sions were

tonic fiexor-exten80r we just as in controls.

1he

untreated oontrol animals

died instantaneously after the appearance of the persistent eonvuleion'h

'the

barbital eroup at the correeponding t i - interval (rive !'Il1nutee) showed emalleJ

protect!" raUos and lea. &biliV to modi.t,y the metruel sei.uN pattern.
'lbe ocourrence ot the delqed death vas not observed.

At one hour post-

adminietration the same dose (SO mg/kg) o! N-al17l barbital showed a. markedly

deoreased. anticonvulsive aet1Vity ..margas the act:tvit7

or

the equal doee

(,0 mg/kg) ot barbital roee in reepect to the protective ratios and ability

to modtr,y seisure pattern although t.'1e delay ot deaths did not uccur.

'.!he

double dose ot ll-allyl barbital (100 "lglkg) proved to be 1I10re etfective at
the oorresponding time interftl than the

50 l'Ig/kg dose 'but the protection

arforded vas belOW' that obeE!l"Y8d at tift minutes post-administration and the

animals showed a more or less t1Pleal sel.UN pattern.

At two hours post-

adMinistration the activity of the 100 mg/kg !'f-all,.l barbital was more decreased than after one hour While barbital potency remained on the same level,

as seen from the values ot 'the proteotion ratios and character of the comulsive pattern.

'lb.e description of the results and the data in the table points out
that the N-allyl substituUon increased the imnediate antimctraaol

act1vi~

of the parent compound but siMUltaneously decreased the duration of action.

'l'he first property is in agrefIHnt with Toman and GOodrltan (1948). who stated
that

~1-a1kyIat1on

inereaau anUmetrazol aotivity.

'Prom these resulte it

appears that the iTtmlediate metabolic product of H...allyl barbital is not barbital as was reported in the ease of t(-mcthyl barbital which wu converted in
ti;e

bod7 into barbital (Butler

metabolic produot of

0Ul."

and Bush, 1939).

'lbe hypothetical oxidative

co1llPOund could ha.ve the diol grouping on the chain

of n1 trogen atom. if the degf'Qdation starte in this place.

More extensi"V'e

oxidation could pruduce 002 and a carboxyl group at the rest of the fragment

on nitrogen atom.
tJU!

But other degradation reactions cannot be excluded e.g.

stability of the barb1turate ring struoture mq be decreased
+

b~'

the

pr~~s-

onee of the allyl radical on nitrogen in a wq analogOUB to the manner in whio
the methyl radio&l on nitrogen atom deoreases the stabilit.y of the ring struc-

ture in alkaline solution (Butler and Bush" (1939).
N-allyl phenobarbital at the same dose (SO mg/lcg,IP) as phenobarbital
at rift minute post-administrat.ion showed interior activity with respect to
proteot.i.'" ratios of the pe1"818tent oonvulsion. but it was more effective in
raising the threshold

ot the first -twitch" and "peeudooonvulsion". Both

COMpounds were able to mod1.fy the first "tv! teh" and "pseudooonwlsion" making

these erreets lees defined.

'!be modifioation

ot the persistent convulsions

phenobarbi tal vu JtUeh MOre pronounced than with N-aUyl phenobarbl tal.

by

" 49
l'h.enobarbi tal abolished the typical tonic con'f'4l.a:l.ve death by
the clonic type death which did not occur instantaneously.

oh~g

:I. t to

'lbe larger dose

of the n-allyl phenobarbital caused ve'1!'Y profound modification of the tirst
ft

twi teh" and "pseudoconV1.1lJsions tt so that only two an1ntls aut of eleven showed

thane 81'l1Ptoma in any reCOgnizable f<)],"Il'l.

'lbe persistent convulsions, in the

majority of cas., shoved a olon1c character which was especiallT well defined

in animals dT1ng non-instantaneous death.

The protective ratios at th1a dose

(100 mg/kg I'?) were higher than those of phenobarbital at dose 50 mg/kg.

One

hour after administration with l~-allyl phenobarbital (100 mg/kg IF) there was

a. marked decrease of the protective ratios and ability to mod1.t,y the character

of the persi.8tent convulaiona.
twent;y-one ani1ll4la.

'lhere was delqed death in three eases out of

The pbenobarhi tal protection at one hour post-injection

twas Incre.ed in comparison to ita l"!ftediate post--injeetion aotlv1't7 with

ir-Pect to degl"H of convuleion modi f'ication and protective ratio.
lOU"

rty

At tiro

post-a.dm.1n18tratlon N-al.l71 phenobarbital showed a lower potene:y apparent-

affording only a very sUght protection as evident .:t.'\'o!'II low protection

ratios and poor ability t.o IItOd1.t)' eonwlsion pattern.

Jut the opposite piC-

t.ure was seen with the phenobarbital group whose protection reached a maxi:tnum

at two hours atter administration.
Mgh, f'J..f'ty-oigbt per cent.

'lbe percentage ot the delqed deaths

'WU

The lethal convulsions were clonic in the majority

':)f these pbenobarbi t.alised mice.
From these reaul ts one m., conclude that n-alql pbenobarbi tal had a

f'!Onsiderable shorter action than the parent.

~d

qualitatively analogous

......_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _-...._,.,""'-'-=
..

',~<I:"__,-J'
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to the way in wbich N...allyl barbital comparee.to barbital.

5uah ruultainrer

the t i te Mtabolic def!'radation products were ditrerent f'1"D1'It phenoba!'bi tal whic

ehowed a continuously increasing QC"tivi1:i'.

lhe compound giving phenobarbital

as a 1"i8tabolie produot 18 ~r..,...'t.h7l phenobarbital.

--

'lhis compound is converted

almost quanti tave11 into phenobarbi tal in vivo as determined from the blood

levels and the tissue coneentratione.

(Butler.. 19$2).

A difference between

the t,",o &u,.1 substitutions in phenobarbital and 'barbital can be noted in that

the N-allyl substitution of }>henobarbi tal did not increase the anticonwlsin
propel"tlea

or

the parent compound a..C) markedly as did the chanv,e tl"Ot'll barb! tal

to W-allyl barb! tal.

'!he latter compound shoved a markedly increased L"iitial

activity over the parent compound, but lacked 8USta1ned action.
The resul t& wi th N-phenacyl phenobarbi tal at 62 mg/kg dose fiTe

Tllinute post-adnd.nistration indioated a moderate protective action and poor
ab1liv to mod:tfy the convulsive pattern.

With incre"'l.sed dose the protective

ratiO did not be0Q!i!t8 higher but a very pronounced ability to change the lett-.al

tonie convulsions to clonic tJpe wss observed.
seventeen out ot went,.-one animals.

nelqad deat.h wea obaerYfHi in

'Ibis delay sometimes r"oached thirty

minutes and several. eelSUJ."e8 ot clonic type occurred before the outcome was
lethal.

S1xty mnutes after udministntion thare va no 'igniticant elevation

of the protect!ve ratiOS over the control leYele and the pattern ot the
vulsiOns was Id.m1la.r to the con ttool picture.

c0n-

At 120 Minutes there was some

indioation of a,nergiem beween this drug and _truol bec&WJe the protective

rattoe at the persistent convulsion level were below uni V.
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'lb_e findings at 120 minute vaiting '!'8" in agreement with those by
Henze arId r:pul"lock (19Ll) who could not detect any anticonvulsive properties
of this <.lOn1pOWld.

Thu would indicate that their determinations were run only

tif'tar a longer time period elapsed following ad:ministration

or

the drug.

The

present rest:lts showed a limited protective aotivity at shorter 'Waiting period!!
with pronounced ability tornrodii'y tho eonVllleive pattem at the five minute

'lhe significance

interval.
stressed

br

ot

the abtlity to modify eonwl.slve pattern 1s

'JX)man, Swinyard, and Goodman (19~6).

cy of t."le antiepUeptic compound !'tay

b$

ihey shoved that the eftica'"

SOl\'.etlmes better related tc the de-

creased abili. ty of the brat.'i to support self sustaining discharges than to a
aL."ple increase in the cbeJd.eal or electrical threshold tor in! t1ating dis-

charges..

'1he o-ast example of this phonoMnon 1& the ability of dUantin to

a1>o11lh the t.eflic $Xten8ion

ot the hind legs of rats caused

by supramax1mal

electroshock 'While on the other hand dilantin is ineffective in raising the

conTulsive thrC'"shold or matraaol.
'lb& following graph, where tho protective ratios of the persistent

eonvu.lsion thrqhold are plotted against time after medication, will help to
S'l.mt'l':'lariB9

the results obtained vi til the tested compoundB. (Figure 1, pg. 52).

lbe question ~ ariae concerning the reliability ot the results
obtained b7 this metraaol :S.n:f'usion technique.

:!he author vas able to demon-

strate that barb! tal at doses, which did not cause any depressive aymptome.
increased the con'VUl..81on 'f:b.Naholds to a moderate degree.
becauso it is known that barb! tal,

8.11 Wi til

'Ibis doubt ari8_

mst CO'rmton barb! turatea, is ef-

.
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'ille prowctive rn.U.O below 1.00

ind1..ea~

'Um:t, thft

~md

acta

s1llof'((....st1oally v1 th _traGl. The prcteotiV6 rnt:i(\ QQ',lAl to 1.00 is the control valu.e. obtained wU;h untreated ani-mltlB. Arr:I Yt'Uu. abovfl: 1.00 1..ndtot,t.that compou.'ld 18 alltagonizing the llletNaol afti,ct.
u

indicated in the graph wah tbft

aCttp~on

that

at t..... live n1nute period in tho dose, 5') mg/kg.

lho

d.o,~a

'~-al1yl

tt.dniniaterEtd aN

oorbi t-Al

WA~

g1van

SJ
fectiy. as an anticonvulsant in the

subcutan~s

causing depressive symptOl!l8 (SVinyard, 1947).

metrasol test only at

d088S

l'urthomo%'e, Orloff 1 8, (191$9)

results with phenobarbital using intravenous met-ruol in.t"uelon indicated that
it is equipotent to tridione or perhaps even

!1Ote

effeotive because 1 t 1'JOdi-

fled the fatal tonlc convulaJions to clonic tqpe and prevented the

specific LlI'1t1metruol aotd.vit.y ('r'Omarl, Goodman and f:Winyard,

OCeUl"Z"{:.nee

1946) anci giVes,

in the 8ubcut&"leoua metratlol &8s.,.., better values tha!) phetiobarbital (O~
and 'l'oman, 19h5).

'.!berefore, it seems that the metruol intusion technlqutl

&1., (1949) 18 likely to rive higher protective rat-loe than the
--

of Orloff at

older 'MOtrase1 methods for dnlge of the barbi turl'lte seri.. _ For this reason

the comparatively good results obtained with N..allyl phenorJ&:rbital and li-allyl

barbital at the peak of $lotion should be accepted oautiouely insofar

tial. clinical application i8 concerned.

poten-

Another limiting factor ill such a

oonsideration is their ehart. duration of acu.cn.

the values for trldione obtained

88

But. the agreement betweGn

1>7 both metruol tests (Orloft et. 81., 1?L9)

gives support to the general validity of

th~

--

retrults obtained by the metrasol

infusion technique.

In conclusion

ot the d:1scuadon it

Clan

be mentioned 'that antirnatruol

ar.t1vit;r 18 01117 a r.onepe:eiticindex for the possible antiepileptic aotivit,.
and does not differentiate the antigrand mal and anUpetit mal. streeti," com...
pounds t~ eaoh other (}~erett, 19L6).

B.

The Barb! turate ReveJ'8a1 St.udies with Succinate.

"Dle8e exper1ment.s were designed to tumieh information whim might

prove he1ptu1 in explaining the antagonisM betveen barbiturates and succinate
demonstrated by some vosers (Soskin and 'fau'bel'haus" 19L3.

Barrett, 191t7).

TUE r r 1,C1S OF SUCC:mATF AND SlJCCmA 'r~MA.LONA 'IE
Otf PEN 'IOBARB! 'D\L Am'S '1I'H~ IA

f'Xp

,to Drug Pre:}a.ratlon
~.

S8,B.ne

~.

Succin:'1c Add

~.

~.

DOse

Average Aneathuta Ito. of

MrJKg. IV Duration in

~.

T
Aninals Value

126

16

212

lOS

9

1.7.4

Succinic Actd Diaod1tma

212

115

20

1.12

SUccinic Acid ntsodium

L2h

99

18

2.71

~. Succtn1. c Acid DUod1Dm

81.tB

MJ

20

,.28

ISuccinic Acid L1.8od111M

Malonic Acid DisodiUlft

;;~

7$

20

5.27

Bu cctniJl11de

212

.,- 118

10

0.6)

Suooinim1de

8ltB

ell

19

3.811

16.
11.
~.

Nf,'t,f'le

All an:tM1.s 'Wont anr:,thetized 'tl"i th pmtob.nrbital. ~~a
88 m.g/kg lp. 'lbe doses of succinic acid in expert~ent6 .3, 11, " and 6 were b.Mi8(i on the ",~ight ot" pU.re
aoid whioh was neutrallHd with equivalent amounts ot
It.ftOH ..
A.ll t valuea presented indicate a probability Of 0.0,$.

The results obtained in experiMent 2, 'fallle Vnl, indicated that
tree succinic acid bad a slight but etaUstleally insignificant antagonistic

effect on pentobarbital anesthesia.

It 'Was of 1nter!8 t to try higher doaee.
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The free suceinie acid could not be used for this purpose because of the possible highly unphysiological changes in acid...base balance which it might cause.
To minimize this possibility somewhat the disodium salt of the succinic acid
was used in experiments ),

4, "

and 6 (Table VIII).

'lbe sma1.ler dose (212

had little revC!rsing effect on the pentobarb1 tal, but the large doses tried

(424

and 848 mg/kg) effected significant rAD'Jet:ton of the sleeping time.

1he

relationship between succinate ion dose and sleeping time duration shCMn in
Figure 2 indicates til.at the barbiturate sntagonitml of succinate if! somewht\t
proportional to the Cbse of 5nceinat.e ion adm:L."1istered.

'lhe~e

results are

Qualitatively Similar to the results obtained by Soskin and 'fuubenh.au~ (19h3)"
,

Barrett (1947).
~I"~~ ti,m-t
\,r1 ..,.,,",

))0
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,
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FIGURE 2

'TSO

'iRE FFFJ<:C T OF SUCCn:A TE ION ON 'IHE DUR}, nON OF '!HE
PElf'lOBARBI'OO. SLEEPING TIME

1000

The resalt8 of
e1.:nate

~.n

te3tinr; the I1t. Davin,: action of

tru.e...

pre-renting the death ot an:btalr. poisoned. with let.ha,l clODe of pentoin~.ieated

barbital

~er11'l1ents

that en..lt-Oinate had no eignU'1cant effect (Table

n).

'lbeae

resttlta are Qppozed to thOft. obtAined by Soekin and 'l'm\b8nhnn.e (19L3) in rata.

'!HE FFFFCT 011 S1JCCmA'lE,
,

POSE' r:r:!

sUCC:mn~IDE

"~f '1'fJ Bft~'F '1"'7". (4

ON THE Lr'lHAt

sormm

Dose
vli;!Kg
IV

Pxp

\fo.
~.

I

D1"'Ug prepttra tion

Saline

~.

!'hlCe! uie ,Acid C:tn
tom of, D1sod.1um eal t)

~.

Saline

t.

,.,

848

8116

Succini.'Il'lide

Pon tobarhi tal Survival

Na.

Ml'jfli,p

IP

Rate

168

1 out ot 13

188

2 out ot 12

l$O

S out ot 10

ISO

6 out ot 10

'lb. succinate 81flergis'l'll to metrazol con:YUlaive action (Table X)

was clearly dtmonstrated by

--al.,

of Orloff at

(19h9).

000

ot the intravenous _truol infuaion tecbniqu

'1he ;)roteetive ratiO of the persistent eonwlaion

threshold was decreased twenty per cent and the convul.lf1ve picture had a
typical metruol pattern.

lllere can be some doubt as to wbether or not thi8

phenomenon is tl"Ue synergism or whether 1 t 1s due to gerural lowering ot the
convulsion tttreabold caused by water balance changes in the bod7.

S"Irinyard,
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'roman and G(}odman (191~6) 'USed 11>01'1\01ar glucos~ parttntol"al iI>'Joc:tJone ami the

l.iubsequont l"6l'::1oval of

&

volume of peritoneal fluid or oOl'lvon;ely ord.l water

feeclinp was utlcd to produce cell h¥dration of t.he an1l1lSl.a.

Tbose h¥drated

s:l1imals shoved both lOWG1"8d lI1(:1;tra.:.:ool and electrcohock throah.:>lds.

t.ion of hyp.. rto1l1c l;acl 8clut:.on

.ul'c.o

'';'he injoc-

hydra::.Gu urd,.:~iln railiad thot>o two

lowered convuls~on t.hr&sbolds to the normal laVlilla or in noI'lw aninlalu it

increased

th~s.

thresholds up to twenty per cent.

It seeNSt.hat the increase

volume of the &xtracfillular tluid did not lower the convulsive t.hrE:loholds.

1neretoN, in the experimtmta performed b:t the a.uthor, where hyportcni<: solutions of succinat& wor8

UlHlad,

one would not

tni.Spect lowering

thrashold on a basiS of e1ectrr)lyte balance cha.nges.

of the convulsive

In add! tion, it was

ahown by Klein and Olsen (1947) that the blood-brain barrier had

Ii

ve17

slight. permeab11lt7 to the suecinate ion 'Which would speak against the pos ...
sible swelling of the brain cells.

believe that the i'q'dratiOl'l

or

It 800ma that theru 1$ no real rauon to

the cell ccmpartmen t could be a oaUlU'! of the

increased sensl tiv1i1y to ntetruol.

'!he work by fiOvet

!!o. !t..,

(1947) .. Heymans

and Jacobs (1947) indicated that succinate htul a ci1rect action on the respiratory center lecated in the lIledulla obloneat& which is senal tive to the
metrazol f,rtimilition also.

On a. basis of these findings and the aut.'lor'e

NBults one would tend to think of the occurrenoe ot summation or syne:rg1n

phenomena between _trazo1 and succina.te ion.
'lb. experiments usiug the combination ot the equivalent MOunts

ot

m&lonic and succinic acid Eodiu1!l salts (Table VI!!, page $lt) demonstrated that

. S6
'I1lBLE X
THF. "~.cT OF SUCC.rNIC ACID DISODIUM SALT, SUCClNDHDE.
suce.TIne AND ~!ALOrlIC ACro nISonIUM SAt1S
It: Co~"ruNPD SOWTIm. ON THE
'ruRfSHOJ..D OF ~f1'':TMZOL
CONVULS IONS
"'

NO.
of

Pers18 tent

no.

Oonwls1one
or
,'xp
?~g/Kg cc or
Ani- CC Of'
An1I P 'Metraaol PR* mals Metrazol PI* ul..8
~o. Pr'llg Preparation
Control

r

0.13

1.00

2L

0.42

1.00

24

0.16

1.00

24

0.$2

1.00

22

848

0.14

0.66

18

a.lt!

0.79

18

Succin1mide
succinic Acid

84B

0.12

0.75

18

o.IJO

0.77

le

D1aodiU!l'l**
tA'a!orlie Acid
DiBodiUllt,H}

1.25

0.11

0.95

19

0.33

0.79

19

tl. 15-17

gm

control.

2. 18-20

3.
~

.•

S.

gm

Suce1n1c Ae1d
D1sodium**

*Protective Ratior
s;.~}

Twitch

375

0'

Tbraehold after treatment

~oi=ml\l

flrM}iold

'Si:t"l"UpondIng weight group

1be dose wu based on weight of pure acid which wau neutralized with NaOH before injection.

such a combination could decrease the duration of anesthesia lIigntt1ean tly
even more than succinate alone at equivalent dose.

'these findings

W(-i!'9

Just

the oppos1te to what one would expect according to tbe soskin and Taubenbaua
(19L)

theory 'Which stated that succinate mq be the main source of energy

tor the barbiturate depressed brain.

the eompeti t1ve 1nh1bi tion

~

....
vl...,t..,.l'.....
O

It seemed that the clar-sical example of

were

malonic acid inhibited the succinic

59
detq-drogenase in succinic acid oxidation was not operating in the experiments
It this were the case one would upect. the dia.ppearance ot

pertormed here.

the sucCinate barbiturate antagon::tn.

On a buis of th. .e elq)eriMntll the

author is inclined to think that the metabolic action ot succinate was not
very iJI'tPortant to 1 tfJ effect in the reversal of barbit.urate dlfPl"8881on.

'lb1a

conclusion 18 in good agreement with Klein and Olaon (1947) who etated that
succinate, due to ito slow diftUflion into
potent1al

eMrgJ'

source.

brain~

could not be

Iri add1.t1on, the evidence

!!!. ~tro

COrB idered

as a

suggests that

--at.,

8\\Cc1nic acid oxidation 1e not coupled with phosphorylation (La.."'"dy et

19Uh), or the increased

~

consUMPtion caused by succinate was not capable ot

increu1ng the "te of the depre5seci metabollc processes (FUrcbgott and
Shorr, 19-h8).

'Ihe presence of synergism btttveen metruol and a combination at

succinic and malonic acids ('Table X) would indicate that succinlc acid could
exert itl antagonistic eftect on barbiturate depression b7 ita st1mulltting

action on ner"fOWl system, al though this 8 timula tlng power i8 tllOiweak to revel'S. the etreats of lethal doe .. of pentobarbital ('l"able IX).
'lba results w11h lueolnim1de at 'b«> dilt.roo t doe.. shwed that the

duration ot anoeth..ia was decreased in both case. (Ta.ble VIII).

'!he effect.

of the ~r,reater doe_ 81Jl tfJ(I/kg, I.V. va ueaker than nth sucoinate at

doS8

Sh8 mg/1cg I.V. or with combination of succinate and malonate at the given dOS€'D
~lonethele88 this

effect was atat18t:leally signiticant.

'Ibe "suite in Table X

indicate the pl"'H(mce ot a synerg18111 between metruol and S"..lccinimide, the

.
possible _chanin tor which haa been
reasons for

tr:y1n~

d1sC'llS8e~

1n preceding paragrap:It!1.

The

t.h1s oompound as a barbiturate HYel'8ing agent were its

che"'lioal structural 81m11arlty to succinate ion and beoause it could be ad1"\iniste:red in large doses without 81multaneoUB introduction ot buic ions
which could themselves exert some influence on the duration ot anesthesia or
metruol Sj'net"gism.

'the resnlte obtained indicate that succ1nWde vu simi-

lar in aetlon to succinate in respect to the shortening of sleeping time
synergism v.i. til metruol and ineffectiveness in preventirlg death from lethal
doses of pen tobarbltal.
'From the results obtained the author is inclined to think that the

role of euceinic 6.010. or its dert.fttlve8

88 ..

souroe at energy is not an im-

portant aspeot of 'C'.,;! 8ucc1na te action in the barbiturate depr(?'ssed animal.

Its role

80

a nervous

87$tem

st.hl'llla.nt could. be inferred from the demonstrated

synergi.8m with metruol md previous studies by Bovat ~

and .Jacobs (191:.7).

!!,., (1947). He;vmans

Irrespective of the true mechani81'll., the effeetlveness of

t,1t1.a stimulat1ng power , .. Minl'"!4l because thfl author could not danonstrate any

lj.fe-eavinr, action by .ucoinic a.cid end its derlvaUvea . in animals poisoned
with pentobarbital.

c. 'lbE'

Studiee of the Analeptic Properties

ot "S(1,3-ril'tetbylal1yl)

f'thyl B8l"b1 turie Aoid.·

The

pttrpOGe

ot the following e:n:peri:menta wu tc detertrt1ne the ana-

leptic value ot the ',$(1.3-d:il!tethylalt),l) othyl barbituric acid.
'Ihe injection of l~o 'Mg/lcr, intravenously caused the appearance

ot uni-

form 8)'!'1lptoma :in mice.

After the injaction the anllftal8 .ho.....d a very strong

axe! tement which ended invariably wHh convulsive death.

cription of the symptoms 1s as follOVll:

'lbe detailed des-

wild running, jumptng, 1IaOUth bleeding

due to biting of wngue, straub tail reaetion, rapid napiration, tonic clonic
convulsiOns and Uflt'lOordinated leg move"'lfllta after animala weN exhausted and
near doath.

'lb. deaths occurred e1. ther instantaneously after completion

o~

injection (three eases out of ten), or after a five minute interval (Beven
eases out of ten).

'lhe fatal convulsion picture

liM

very similar to that

caused by metrazol £«bib! t.ing the tonic flexor and extensor phases with the
head bent ventrally.

'lhoaEJ observations indicated that the drug had a very

strong convulsive eharacter and was more potent than metraaol on a basis ot
the le 1bal dose.

'nle 1njecM.on of this st1mlating drug after adlWlistrat.ion of pentobarbital did. not

C3U88

any convulsive SjlmPtoMa whieh

BoomB

to indicate that

the convulsive properties ot thia dJoug were completely antagonised by thiS

lbarbiturate.
~o

Thea. tind1ng8 are in agreelftEl'lt with Taylor and Noble (19h9>.,

fJX8l!!ined the phamacolog1cal properties of

tJ~ 8

ane drug in the dOg.

1o:'!1m11ar resul ta were obtained w:tth other eonwls!ve barb1 tllratea by Swanson

and Chat (1939), Knoefel (19ItS),

~foble

(19b.9.

On the buis

ot the et1rm1l.at1ng

IPropertl. reported in 1be literature and prelimiMr.Y tlndinga

by the author

expet".i.menta were undertaken to determine the efteet of this drug on the dura-

tion ot barbiturate anesthesia.

The experimental work ot this aspect ot the

Iletion Qf the ems of convulsive barb1turatell has not been reported in liter-

.
ature previously.

The f'inrlings in Table XI indicate that "the S,S{l,.3-d1methyl

allyl) ethyl ba.rbituric aCid was able to decrease .1gnificantly the dura.tion

anesthesia.

0

'1"hese findings can be indirectly Bupported by the results by

--al., (19S1b) who reported that the stimulating bubiturates could

Vellu. et

antagonize the respira1'l:l Z7 de;:ression caused b.Y morphine and shorten the dura-

tion of apnea after lVPerVEll tllatton in guinea pigs.

'the resulte on the re-

versal of the lethal ettecta ot pentobarbital overdosage 11x:llcated no 6ignlflcan t protection a1 fbough no synergism between these tt«:l drugs was observable.
1heso findings corresponded to those of fwanaon and

~'1.en

(1939), and Knoerel

(19h6, who used sl'1Jtilar convulsive ha.:rhiturates in attempts to reverse the
lethal efrect of barbiturate..
betVC;er\

Tbf\ :first wrkOl"S reported a slipht synergism

depresflive and stbm.lat1 ng barbiturates.
'IABLE XI
nm lCJ:+'FEC'l' OF

5,.s(J,3...D1V~:nfn..ALl.YL)

E:'ffiYL

:1AHBI'tnmc ACID OU THE DEPRmSIVE

AC'rrVI'lY OF' PENWBARBITAJ.. SODIUM
IDoee Pentobarb1 tal

~1g/Kg
~
Pfo. Drug Preparation IV
rt. >.5( 3,J-DimethYl-

allyl

'~';Kg IP

Rt.hy'l

Bar{,i turie Acid
Na Salt

2. Same ae in
3. Saline

!·,~a

1.

Results
Average Sleep-

No. ot
Anit
male Value

ing T1M -

hO
ho

8B

188

88

62

~tee

13

Six died out of
twelve animals
12
Average sleeping 'l'1me -

126 t.f1nutea
IJ~.

Saline

.

?~otef

1CE

16

Seven died out of
twelve animals 12
t value presented ind1cates a probability of 0.05

5.62

63
~

On a basis

ot

tbase findings it is concluded that the $.S(1,3-01-

.

1'!!ethyl8,lly1) ethyl barbituric acid exhibited antagoniSm to pentobarbital

at the dose tested, as shown by the decrease of U. 818sthetlc dul-ation, but
was W1thout erroct on the lethal effect of pentobarbi. tal in lliae.

"aut te should be transfe1"J"ed to other

SpEI Ci.8

'lhase

wry caref'ulq- because great

tion of this class ot barb! turates (Swanson and Chen, 1939,

>

Richards, 19.5l).

.

~tudi_

have bmm undcn-taken to evaluate the pha.nacolog.lcaJ. effects

or N-alkyl wbsti tutions on hypnotic ba:rbi turate !'I\Oleeulee. It has been asoertained that !l-alkyl lJubati tut10n wl th the allyl radical on barbital pro-

duced a quantitative increase in the intensity of the ant1convuleant activity

of the molecule as me.u.red by the intravenous metrasol intll810n test. SUch
subst! tu ti on decreased the lata'lt penod for manifestation of the peak of

antlconvuleant activity by barbital but also seemed to decrease the duration
of suob acUrt ty.

N-aUyl 8ubsti tution on phenobarbi tal yielded a compound

w:tth acmevhat reduced ant1con'YUlsive potenq.

In addition, this structural

at teration of the phenobar'bi tal molecule decreased the latent penod. ot the
peak

ot action

and the duration

ot such activity.

U-phenaC7l substitution on

phenobarbital yielded a compound wi th reduced anticonvulsive etfect and a possible S;yt'l8rg18t1o effect with Metruol late in the course of i te action.

No

analoO' to the morphine reft'l'81ng effect of tl-allyl nomorphine (N-allyl sub-

st1 tuUon on morphine) was seen in the case ot expelimenta in which 1t-allyl
barbiturates

weN

used in attempts to effect revel"8al of the snesth88ia and

toxiei t7 erreeta ot hypnotic barbi tura tea.
synergistio nature.

'lb. oba....ed effects were of the

At doses tried, the alkyl 8ubstl tllted compounds exh1bi ted
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increased inttl1s11;y of anesthetic potency over that demonstrated by the parent
'Ibis anesthesia was charactel'lsed by short duration, swift induc-

col'!'JPOunds..

tion and fleeting post-anesthetic depression, all being properties in direct.

contrast to thoac of the parent. molecules.
F:Jq>.:r1menta with succinic acid, succinUdde and a combination ot succinic and malonic acids indioated that these CClMpounds and thia combin<ltion ot
COl'l1JJOUnds

decreased the duration of pentobarbital ar.esthes1a tmd showed a syn-

ergistic action with metruol in intravenous _truol infurrton t.6G te.
the protection afforded b;y theee {:ompounda agatns t lethal

dOf:le8

!~ 80,

of pento-

barbi tal vaa negligible.
Analysis ot the analeptic effects of a convuJ.sive barbiturate

(3,)-d!methylal1yl) eth1'l barbituric acid wu carried out.
hib! ted high

6 tlmulat!"Ie

S,S

1hls <.'QTIlpOund ex-

potency Q..'ld caused a reduction in pen tobarbl tal

anesthesia duration but was

wi~out

etfeet on the lethal dos. of pentobarbital

.
BIB!.. JOG RAf'HY

Adams, J.P., Jr., Lareon, 1':., 19$0. Analeptic rftect ot Succinate, ~lonat,e,
Citrat.e and Acetate on Pentobarbital Sodium. Fed. Pree", 9:252.

J.,

Adrian!,
1942.. The Pharmacology ot Anesthetie Drugs, 2nd ltiition,
Charles c. 'Itto'maS, Publisher, Springleld, Illinois, Baltimore, Maryland.
Alles, a. A. , fl.l1.s, C.li., 19L9. Com;;arat1ve C8'ltral Depressant Action of
Some S"Phenyl - 5 Alkenylbarbi t;~rlc Acids. J. Pharmaool. [,; FXper.

Therap;, 9St )52-)59•

.i

I

Alles, O.A., 1:"'1l18, C.H., Fe1gen, O.A., Red_an, M.A., 191,a. Comparatin
Cmtru :CeprO:::8otlnt .Aet.ion of !~ome S... Phenyl ... ;; Alkyl 13arbltu.l'ic Acids.
J. ?hAl">Mcol. &. J:xper. '!herap., 89: 359-)67.

Anderson,

c.t.,

~rl1"lenta1

1949.

Production ot Convulalve Seisures.

J. \lierv. f:c ~fent. DIe., l09t 210-2l.S.

Ballen, 0.14., Noble. R.t., 1·rebeter, D.Il., 19u8. A New ParU)'IIIPathetic
Stbm:llant, Eth)f'l, J. J Dimethylallyl ~arbi turin Acid. Can. f~.A.J.,

Sea Ma-hSO.

r.a., Ste1n-Jensen, iT., 1946. The Action of ni-Allyl Barb:lturic
Acid on the f:leetrieally Induced 'Rpileptie Fit. Acta Pharmaeol. et

Barany,

~xiccl.,

2: 26L-267.

Barrett, R.H., 1947.

'lbe Analeptic R!feet of lia Succinate on Barbiturate
Cl.U'T@nt Res. in Anesth. !':. Analg., 26, 74-81.

Depression 1.."1 Man.

Beyer, K.H., rAtven, A.R., 1941.... An r:valuat.i.on, ot the Innuenee ot
Succinate and ""..lonate on Barbiturate flypno,d.a. J.Phamaco1.

FXper. Therap.,

81~

plicke, 1",1'., Zienty, M.F., 1941.

Doc., 63: 2991-2993.

$.:

20)-208.

Acid AMides as Hypnotics.

66

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _.....

,;:::.:.....c:::-~-"ty.a,.'!'"·.

J. Am. Cham.

..

67
BoYet, D., MonOd, J. , ];Wolf, A., 1941. iiXitation per l'Aclde suec1nique
du Centra Reepiratore du Chien due Apnea. d'JOperventUation.
Compt. Rend. see. Biol.. 221n IBbh-181..6.
Brody, T...... , Bain J., 19$1. r';f'teet ot Barbiturates on Old dative
Phosphorylation. Proo. Soc. fxper. Biol. &
77: ~S).

Med.,

BQek, J.S., Hjort, A.M •• Ide, W.S •• DeBeer, 1:;', 1938. l-N Al.kyl
IsowVl Barbituric Aoids. J.A.'M. Chem. Soo., 60. h61-463.

S,S

Eth71-

Bn.rger, A., 19S1. lfedieinal Chemistry; Chemistr:Y. Bioehem1str,y, 'lherapeut1c
and PharmacoloKical Aotion ot Natur'6l. and SJ'nthetic Dr.1.. New York
tnteracience Publishers, Vol. 1
Bush, M.T., !\ltler, '1'.0., 1937. ~traalk.71barbiturlo Ao1da.
t:r F~81". 'Iherap., 611 139-147.

J. Phanlacol.

Butler, 'r.e. J 19$2. Quanti tative studies ot the ~tetabol1c Fate of Mephobarbital (N .. Meth11 , Phenobarbital). J. Phamnool. & ~r. 'Jherap.,

1061 23.5-2L5.
Butler, T.O., Bush, 'M. T., 1939. 'Ibe 'M'etabolle l"ate of N-Metiql Barbiturie
Acids. J. Pbarmacol. &: F~er. 'l'berap.. 6Sf 2OS-213.
Butler, T.C., Buh, M.T., 1942. Anellt.het.ie Activit,. ot Some Nw ller.t.vatives
of Darb! tlui.c Acid... Proc. Soc. tJcp8r. Biol. &: Med., SO. 2.32-231...
cahan, R.L., 1946. On the Anticonvulsant Activ1ty of Var10U8 N lIeteroqc1es.
I Alkylthioether barbiturates. II Phen;rla.l.k71thiometb71h1dantoins •
•1. Phamacol. II rxper. 'Jherap., 88: 343-352.
Chen, 0., Pol"'tman, R., FJ18or., C.R., Bratton, Jr., A.e., 19S1. *lb.e .Anticonvulsant ActiviV of ~Phen7l Succinlm.des. J. Pbarmaco1. &
Exper. '!herap., 10): Sh-61.
Chenoweth. M.B., St. John, E.V., 19h7.
in 'f,ega F:En by' F10U1"0acetic Acld,

26c 299-)07.

Spike and Dome Format.ton Produced
Res.
A. Ne". /( Ment. Di.•• ,

Publ.,

Cope, A.C." Hancock, E.M., 1939. Substituted V1nyl Barbituric A~!d8.
II Derivatives fkmta1n1ng Dla.lkylvinyl Group Having S or more
Carbon Atoms. J. Al'It. Chem. Soc., 61« 116-779.

?I.,

(,,ope, A.O., Kovacic, P. , Tlurg,
1949. Spirobarbituric Acids Containing
f\1x-~_bered Carbocyclic Ring. J. Am. Ohem. S'tOc., 71: 36)8-3662 •

Ii
I

Corson, S.A., Koppcq1, T., V1vino, A.r., 191.&$. Sttldiu on Barbitura'bU
XXVIII. Fff'ect of Succinate and P'uPI~t"ate in E:xperia~al Barbiturate Poisoning. Current Rea. in Aneth. &; ~., 21u 177-1921••
D3'ri.s, P.A., sulzbach, 1940. Changes in EFll During Matrasol 'Ibarapy.
Arch. liIeu.rol. &: i>.,.chiat., L..3. lh1-)$$.
Dox, A.\"I., Hjort, A.tt.,.., 1927. The Relative Physiological Properties ot
Certa1.."'l Malky1 a."ld Dt alkyl aarbitlU"ic Acids. J. Pharmaool. &.

E:xper. 'lherap.,
})Ox,

A.W., and lod_,

enem.

II,S-L72.

)It

t., 1m.

Alkylbensyl Barbituric Aeida.

J • .Ant.

Soc., hln llla....lll6.

F.ckenhott, J.r., Hot.f'1Wl, o.t., Dripps, R.D., 19$2. N-All1'l NomorphL"18 ...
An Antagonist to the Opiates. Anesthesiology, 13: 242-2$1,.

lho l:";f'teet of Pentobal'b1W on Aerobic
Phospho:r;ylat;,ton in Dzoain Homo,enates. Arch. Mochem., 20. l63...165.

Riler, J.J., Mol"Wen, W.K., 19t;9.

m.eberg, e.A., ~~tookq, D.P., 1923. [=;tudiee on EpUepsy I. Oonwlsions
lzperillentaliy Produced in Anima18 COmpared With Comrula1ve Statea
in 'f"'an. Arch. ~leurol. t< Psyebiat., 9: 613-626.

!'Yerett, 6.M., 1946. AntleonY'alsant Aot1on of nruge Aga1net Ketrool
and Anti-epUeptle Activitq.

Pede PrOc.,

S: 26.

l<:verett, G.v,-., Rienards, R.K., 1944. COmparative Anticonvulsant Action
or ),$,$-'l'r1ntettvlousol!d1ne .. 2,ft-Dione( Trid1cne) DUant'1n and
Pbmobarbi tal. J. Pb8.1"!ltuol. & fXper. 1.'herap., el: uo2-407.

a.M., R1chards, R.I., 191.5. ~arative Antioonvulaant and
IlYPnotie Action or Some Barbituric Add Derivatift.. Fad.

'FVel"ett,

4:

20.

Proc.,

.

twerett, 0.1-'., 'l'or!1an, J.E.P., 19$1.
and AntlepUeptie DrugS_

Fieeel',

t.,., neser,
M., 19S0.
Co., Boston.

Fed.

~ ..1menta1

Proo.,

Psyoboaotor SeisuretJ

10, 293.

Organic Chemietry, 2nd F.d1 tian,

D.C. Heath &

Fuh1"!'8\, F.A., MBI"tin, A.W., Dllie, J.M., 1941. 'lbe Inhibition ot
Brain OXidation b7 a ConY'tt1eant Bar'b1t,urate. Science, 91n 421-!t22.

l

.

Furchgott, R.F_, Shorr, E., 1948. l\te f-:ffeot ot Suocinate on Respiration and.
Certain Metabolic Processes of t~ammallan· '1188U. . at Low 02 'IW18ioDD in
Vi trow J. 13101. Chern. 17S, 201-215.
(]oodlun. t.S., are"a1, Singh, M., Rrown,

ot

w.o., ed Sw:1..n1'Vd, F..A., 19$).

Maximal. ~e1zure8 F~ked by Pentqlenetetruol (Metraaol)
and 'fl.eetroehock in Mice and 'I'ooir Mod1tloati.on by AnticonYUlaantl.

CompariSon

J. ?bamacol. &: FXper. 'Iberap., lOO! 166-116.
GOOdman, t. , 'roman, J.F:.P., 1916. F:xperimental Indices tor ('.ompar1ng the
Efficacy of COMpOUnd. with Anticonvulsant and AntiepUeptic Properties.
Fed. FrOG., h: 120.
GOodman" L.S., Toman, J.J~.l'., SvL.~d, B.A., 1946.

Anticonvulsant
PrOperUes of Tridione. Laboratory and Clinical Investigati.on.
AnI. J. Med.., 1 t 213-22'8.

nr1eg, M.:r:., 19L6. '1he Site ot Action of Narcotics on Brain Metabolism.
J. Pbamacol. ~;:. ~er. Tl\r::rap., 87t 185-192.
Grieg, M.E., 19h7.
or Bra1n

'lbe ]'i'J'feot or Ascorbic Acid in ReduCing the Inhibition
Produced by' Pentobarbital in Vitro. J. Pharl1'l&eo1.

~f.ta.bo1isM

& F~. Therap., 91, 311-32).
Oneg,

~.F.,

19$2. Failure to find a lleversal by :sAL of the Pentobarbital
or Brain 'Metabolism. J. PharTl'laool. ~;; E:xper. Therap., 106,

Inbib1 tion

2la-IB.

Hart, E.1t., 194).
~rormorph1ne

Renze, H.R. and
barbi tal.

Further Observations on the Antagon'.t;tic Action ot N-Allyl'Fed. Proc., 2: 82.

Against Morphine.
Sp~loek,

J.J., 19L1.

N..~ubeti tuted r:er1vativ. of P}:umo-

J. AM. Chem. 800 ... 63. ))60-336).

J.,

He.J!It8I18, C., Jacobs,
1947. Action due Succinate de Bouda sur Cax
Reep5. m t!on. F:xp~:rient.ia.. 3. 291+-29S.

Hugg1n8, R.A., Glus, w.o., BrJran, A.R... 19$0. PrOteotive Aotion or n-A11;yl
Normorphine Against Respiratory Depression Produoed by Some Compounde
BelAted to 'Morphine. Proc. Soc. Exper. Biol., N.Y., 7S~ Sho-SL1.
Johnson, H.C., Walker, ;\.E., 19$2.
to I.V. Cld ToTJioal 'Metraao1.

Response of Experi1Hntal Epileptic 1"001
F'leotroeheephalog. fit elin. 'tfeuJlOphy$io1.,

lu 131-139.
Kal:L"lowsk,-,

t.P., Kennea;"

F.,

19LJ. Obufi"Vaticm in EJ.eetro Shoek 'lberapy

Applied to Problem of r~11ep.,...

J. Nerv. & '·(ent. Dis •• 98 • .$6-66.

l

70.
Klein, J.R., Olaen, N.S., 1947. lJ15tribution ot I.V. Injected Olutamate
lactate, J7:ru'Vate and Succinate between Blood and Brain. J. Biol.

Chem., 167: 1-5.
Knoerel, P.K., 1936. lh. Action of a oonvulsant Barbiturate.
& lbIper. 'lherap. (1'MO.), 57: 130.

J. Pharmacal.

Kneetel, P.K., 1911S. ~t.1m1at1on and r.eprassion ot C.N.S. hT Derivatives
ot Barbiturio and 'lh1obarbituric Aoid8. J. Pharmaool. &: Exper.
Therap., 84: 26:33.

r...M., Barsera, S.E., 1942. Recurrent Convul..slve Se1auree

Kopeloft,

Animala Produced by Immwrl.logieal ald Chemioal Means.

in

Am. J.

P81chiat., 98. 881-902.
La"'lSon, p.n., Gricg, M.j;,., Hobdy, Ch. J. , 1951. 1~odif'1ca.tion of Barbiturate
Anesthesia by Glucose its Intermediate l"etabol1 tee and Certain Other
Substances. J. pnamacol. &. IJlper. 'lberap., 103: 460-470.
T..ardy, M.A., Hansen, R.O., Phillips, p.a., 19hh. Ineffectiveness of Sodium
Succinate 1n Control ot Duration ot Barbiturate Anesthesia.

Proc. Soc. Exper. Biol. & Med., 5st 277-78.

r..arrabee, M.G., RalItOs, G.J., allbring, E. , 19$0.
Nerve

C~ls by DepresSing

O2 Consumption.

""'0 An_thetics Depress
Fed. Proc., 9: 7S.

~tennan,

H., Klliot, K.A.C., 19S1. Fl'fects ot Convulezt and Narcotic
D1"O.g8 on Acetylcholine SJn,thesis. J. Pbarmacol. c« ~er. 'lberap.,

103, lS-lt3.
T~OX, 'rti.G.,

Nelson, R. , :Reatha'lDt W.P., 1929. Studies in .t:pUepq-.
VI Factors Affecting Convulsions Induced in Rabbits. Arch. Neural.
&. Psychlat., 21: 62S-636.

T.,

?A'emtt, N.H., Putnam, J.
1938. A New Series of Anticonw18ant
Drugs Tested b7 ~erimente on Animals. Arch. tfeuro1. & PByohlat.,
39: 100)-101$.

'M.,

Mlcheallis,
Quutel, J.B. , 19L1. 'lbe Site of Action of Haroott.
in Respiratory Process_. Blochem.
lSt $18-$3l.

J.,

Noble, R.t., 19u9. St1.Jlulntion and Inhibition ot Outric Seoretion
in Cata b7 Barb1turatea and Thiourea Deriyatl'ft8. Can. M. A.

60.

Ss-ss.

J.,

Orloff, ?l.T., Williams, M.t., Pfeiffer, c.e., 1949. TiMId IntraVenoue
rnfu810n of ?l.ef.rU01 and St.'r.7chnine for T'eat1ng AnUoonwlaant D'rUgs.
Proc. Soc. p;xper. Biol. &
70, 2Sh-2S7.

'Ked.,

PeNley, H., Goldstein, M.S., Lav1ne, R. , 19S0. Mechanism of Barbiturate
Action. .1. Pharaeol. t:: rxper. 'Iberap., 100, 273-283.

Pinsohmidt, :;l.W., Rase,", H.B., Haag, 1945. Antagoni81'l of SOdiW!l Succinate
to flarbiture.te Depression. J. Pharmacol. &. r;xper. 'lberap., 63: '-1$-$2.

1937. Fxper1mental Deteminat10n of the Anticonvul.eant Propert.iu at Some Phenyl Per1vativu. Science,
S2S-526.

Putna.'I'II., T.J., Merritt, tel.H.,

ass

CuMul, J.R., Heath1e)", A. r,.~., 1932.
PrOe. Roy. Soc. _d., IDa 00-79.

Narcosis and OXidation of the Brain.

Richard, R.t., 19)1. Studies on "convulsive" 'lhiobarbiturates.
Current RElB. Anesth. & Ana1g., 30: 3h8-3S).

Sandberg, F., 1949. Pbama.cological Properties of Some New n..Subotituted
Barbituric Acid Derivatives. Acta. Pb1'siool. Scandinav., lS, 20L-217.
Sandberg, F., 1951. Anesthetic Properties of N-SUbstitllted and 11' -Disubstituted Derivat.ives of S" D1al171 Darbituric Acids. Aeta Physio1.
f-candinllW., 21u 7-26.
Sexton, W.A., 19S). (.,"hEmloa1 Constitution and Biological Activity,
~eODnd Fd1t1on, D. Van Nostrand
Inc., New York, 1bronto, London.

Co.,

Shack, J.A., 19L9. 'lbe analeptic fffect of Na..tiucc1nate in Barbiturate
Anesthesia in Rabbi ta. J. Ph8l"'l?!aCol. It }iXper. 1't1erap., 96. 315-324.

Shonle, H.A., 1931. 'Modif1cati.on of H)'pnotie Aotion 1hrougb Cbalgea
in Chemical Structure. J. Ind. F..ng. Ohem., 23t 1104-1108.

Shonle, H.A., Doran, W.J., 1936. Dl-Alk.11 and T.r1-Alky1 Barbituric Acids.
J. Am. Cham. Soc., ,8: llse-llS9.
Shonle, H.A., Waldo, J.H., 1933 •. A stuq of the !':ttect ot Un.8aturated
Aliphatic OJ'OUpa in Barbituric Acida. J. Am. Cbem. ~oc., SSt L649-4652.
r'!!1itb, C.C., 'Lehman, E.G., 0i11i11on, J.t., 19S1. Antagonistic Action
of N-Allyl-Hormorph!ne Upon Analgetic and Toxic FffectB or Morphine,
••thadone Der1ntifts and r ft onipoca1ne. Fed. Proc., lOt 33S-336.

t

" I,

12.
~. Taubenhaus, M., 1943.
Barbi turate Po18oning and in
turate Anesthesia (Including
turate Poisoning in Human).

Soskin,

Sodium ~::ucc1nate as. an Antidote tor
the COntrol at the !Juration ot Barbiite Successful U•• in a Caae ot D arb1J. 'Phar1'l4co1. &: bper. 'lherap., 7th

b9t5S.
Bpi.pl,

f~.A.,

1931. (iuanUta.t1ve fleterm1natlon of Conwl.sive Reactivitq

by Flectrlcal stimulation of the Brain vi th the Skull Intact.

J. Lab. &.

cUn.

Med., 22r 127h...1276.

Straus, H., Iabm, W.F.. , Jr., 1939. Reactions ot the Fl.ectroeneephalogram
to !letI'Uol Injection. Free. Soc. ~el". Biol. &. Med., 40t 1-2.
SWanson, I<:.li~., 1934. Relationship beween Pharmacologioal Action and
Chemical Structure of Barbituric Acid Derivatives. Proo. Soc.

h'per. 13101.

It. Meet., 31t 961-963.

SWanson, E.F;., 1936. Nitrogen A1ky'l Barbituric Acid DerivatiYee.
J. Am. Pharm. A. (Scient. Rd.), 25t eSB-as?
F>wmsOft, t.E... Chen, .K.Jt., 1939. '1'be Aberrant Action of Na 1:3 Dimethyl
rutyl-Etbyl Barbiturate. Cuart. J. Pham. & Pharmaeo1., 12t 6$1-660.

swanson, E.l::., rr,y,

w.o.,

Acid I'ler1vativee.

1931. 2-«eth;y1-Al.lq1 Substituted Barbituric
J. Am. Pbam. A. (Scient. Ed.) 26: 311-319.

Swanson, E:.E., Frl, 'W.e., 19ho. 'Lh. 'Ph~aco1og1ca1 Relationship ot
Isomeric Barbituric Aeid Denvati".. J. Am. Pham. A. (Scient. F4..),

291 $09-514.
Bwa:naon, :E.B.• , F'Z7, \11.0., ReGgan, O.W., 1945. Barbituric Acid Derivatlvea.
Pharmacologieal RtUationshlp of a Series 01 Buten71-Al1ql Parbituric
and 'Ih1obarbiturie Acid Compounda. J. Am. Pha1"lll. A. (Seien. Fd.),

l4: 18)-181.

S1>.1.nyud, r;.A., 1947. ValidiV of taborato17 Anticonvulsant Teet tor
Predicting Antlepileptic .Potenc::y and Specific! ty. Fed. Proc., 6, 316.

SW1n1ard,

E.A., Brown, W.C., Goodman, L.S., 19$2. Comparative A8S&J'8
of Ant1epUeptic fJwga in Mice and Rata. J. Ph21'l'll8.oo1. & Fxper.

lherap., 1061 319-330.

SW1n1ard.

E.A.,

'loman, J.E.P., Goodmen, L.S., 191.6. k"l'.feet of Cellular
Hydration on EXperimental Fl.ectroehoek Convulaion. J. Neuro~i01.,
9r b1-$h.

'l'Ihem, D.L., Volviller, f..H., 1935. Sulf'ur ~ta1n1ng Barbiturate
Hypnotics. J. Am. Chem. Soc., $7, 1961...1963.
Tabem, n.t., Volwlller, £.H., 1936. N-Alky1 and U-Ar;yl Substituted
Barbituric Aelde. J. AM. {bam. Soc., 5th 1354-1358.
'!aylor, H.B.G., Noble, R.L., 19h9. Some Pharmacological Properties of
r.a rthy1, 3,)-dimethyla1lylbarbiturate. Na.ture 1631 4h7.
'I'oma.n# J.r:.P., 1951. Neuropharmacological Consideration in Psyehie
Seizures. NelU'Ology, 1, Wdt-h60.
'l'bman, J.E.P., Da:vis, J.P., 191,9.

Actin V of the :Brain.

lhe F:f'fectB of DNg8 Upon Fl.ectrical
J. Pha.rmaeol. leI rxper. '1herap., 97: ,425-492.

Toman, J.F:.P., Goodman, t.s., 1947. Conditions Modit)ing Con't'Ulsione
in An.:lma1e. A. Rea. iierY. &. Ment. Dis., Proe., 26: 141...162.
~, J.F:.P., Goodman, f#.S.,

b09-It)2.

1948. Anticonvulsants.

Ph1Biol. RAY-, 28t

Toman, .l.E.p., Goodman, t.8., Swinynrd, E./t.., 191.6.

the C61tral Excitato1")" fffects of Metrazol.

Observations on
Fed. !'roc., 51 208.

Toman, .l.E.P., Hendley, C.P., 191~8. A Comparison of Action of Ant:tconvulsants on the Fxci tabU! ~ of' Peripheral Nerve and 'MOtor Cortex.
Am. J. PhyB., 1S5r li72-Ii7).

to,ewe, 8., noodman, L.S., 1947. Studies on Physiology and
Therapy of I..ionvul s lve D1aordel"8. I The F!:f'ect of Anticonvulsant tlr'U.g
on 'l<leetroshoek Seilurea in ~Ian. Arch. Neural. & PBychiat., S6: 312-

1bman, J.R.P.,

32L.

'lbman, J.~.P., S1rlnyard, F:.A., noodman, e.s., 1946. Properties of ~
Seizures and their A1 tera tion by An t1 conwlsan t Drugs and other Agents.
J. Neurophysiol., 91 231-239.
Antagonistic I·:rteet of 11-Allyl - !'lomorphlne Upon ~rph1ne •
.l. Phamaool. &. Esper. 'lherap., 79: 27-31.

Unna, R., 19L3.

Vellua, L., Jequ1er, R., Peterfalul, M., Teodoru, 0., Plotka,

e.,

Allays,

1951a. Analeptiques RespiratoireB en Serle Barbituique III.
Ann. Ptulmaeeut. Franc., 9, 2R3-m.

Vellus, t., Jequ1.er, n., Tevdoru, e., Plotka, e., Mathieu, .l. 19S1b.
Ana1eptiques .tieap1ratoirea en Serie Barbituique IV. Ann. Phamaceut.
Franc., 9. 292-299.

Webb, J.t., Elliott, X.A.C., 19$1. F£,teet of Narcotics and Convulsant. on
Tissue 01700lysiD and Reepirat1.on. J. pnarmaco1. & F,xp. 'l'berap., 103.

24-34.

r.Ye,sttall, B.A., 19L6.

P;yruvi~, Acid AntagcnilllJlt to Barbiturate Depression.

J. Pharmacal. & F,xper. lherap., 87: 32-37.

Westfall, B.A., 19L9. 1,:tfect of Pentobarbital on Ox;ygen Consumption by
nrain Slices. J. Phamaeol. &: }"Jtper. 1herap., 96. 193-197.
Westfall, B.A.., 19$1.

lbe EJ"feets ot Pentobarbl tal, Amobarbital and

Barbi tal on 02 Consumption
1heraw., 101. 16.3-166.

o~

Brain Sliees.

J. Pharmacal.

&

rxper.

Wh1eldon. J. 1:., van Haneve1d, A., 1951. Drug l'ffects on the M1n1:m:al.
Cortica.l tti.'I\'I!llat1on. Eleetroenoephalog. & Clin. Neu.roph18io1., 3t
31-3S.
WoodbuJ7, T".A., Davenport, V.D., 19$2. r-eeian and Use ot a New Flectro...
shock SeDura Apparatus and Anal7lis ot ,actora A1 tot"lng SeUure
'lhreshold and Pattem, Arch. Internat. Pharmeodyn., 92t 97-1()7.

'lbe theeis submitted by Jonas A. 07118 haa OOEl'l read and

approved by' three members of the faculty ot the f1tritch School of
Medicine, Loyola University.

']he final copies have been examined by the director ot
the thesis and the signature which appears below verities the
fact that any

OOe()8f!8.l"y

changes have been incorporated, and that

the thesis if! now given final approval vi th reference to content,

rom, and mechanical accuracy.

"'!ent

ot

the requil"9'nEmts tor the Degree of Haster

ot Science.

